10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

OR
 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to __________

Commission File Number: 001-36894

SOLAREDGE TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware	20-5338862
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)
1 HaMada Street
Herziliya Pituach, 4673335, Israel
(Address of Principal Executive Offices, zip code)

972 (9) 957-6620

Registrant’s telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.0001 per share	SEDG	NASDAQ (Global Select Market)

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

  Yes ☒       No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

  Yes  ☒       No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller Reporting Company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐       No ☒

As of May 1, 2023, there were 56,344,727 shares of the registrant’s common stock, par value of $0.0001 per share, outstanding.

TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION
ITEM 1.Financial Statements	F-1
Condensed Consolidated Balance Sheets	F-1
Condensed Consolidated Statements of Income	F-3
Condensed Consolidated Statements of Comprehensive Income	F-4
Condensed Consolidated Statements of Changes in Stockholders’ Equity	F-5
Condensed Consolidated Statements of Cash Flows	F-6
Notes to the Condensed Consolidated Financial Statements (unaudited)	F-8
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	3
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk	14
ITEM 4. Controls and Procedures	15
PART II. OTHER INFORMATION
ITEM 1. Legal Proceedings	16
ITEM 1A. Risk Factors	16
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds	16
ITEM 3. Defaults upon Senior Securities	16
ITEM 4. Mine Safety Disclosures	16
ITEM 5. Other Information	16
ITEM 6. Exhibits	17
EXHIBIT INDEX	17

2

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

SOLAREDGE TECHNOLOGIES INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in thousands, except per share data)

	March 31, 2023		December 31, 2022
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	727,849	$	783,112
Marketable securities		410,820		241,117
Trade receivables, net of allowances of $4,422 and $3,202, respectively		969,543		905,146
Inventories, net		874,212		729,201
Prepaid expenses and other current assets		259,642		241,082
Total current assets		3,242,066		2,899,658
LONG-TERM ASSETS:
Marketable securities		509,127		645,491
Deferred tax assets, net		46,612		44,153
Property, plant and equipment, net		556,138		543,969
Operating lease right-of-use assets, net		69,710		62,754
Intangible assets, net		17,933		19,929
Goodwill		29,934		31,189
Other long-term assets		24,906		18,806
Total long-term assets		1,254,360		1,366,291
Total assets	$	4,496,426	$	4,265,949

The accompanying notes are an integral part of the condensed consolidated financial statements.

F -  1

SOLAREDGE TECHNOLOGIES INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Cont.)

(in thousands, except per share data)

	March 31, 2023			December 31, 2022
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Trade payables, net	$	408,523		$	459,831
Employees and payroll accruals		90,853			85,158
Warranty obligations		129,278			103,975
Deferred revenues and customers advances		27,507			26,641
Accrued expenses and other current liabilities		243,881			214,112
Total current liabilities		900,042			889,717
LONG-TERM LIABILITIES:
Convertible senior notes, net		625,182			624,451
Warranty obligations		313,693			281,082
Deferred revenues		196,917			186,936
Finance lease liabilities		43,711			45,385
Operating lease liabilities		50,855			46,256
Other long-term liabilities		15,232			15,756
Total long-term liabilities		1,245,590			1,199,866
COMMITMENTS AND CONTINGENT LIABILITIES
STOCKHOLDERS’ EQUITY:
Common stock of $0.0001 par value - Authorized: 125,000,000 shares as of March 31, 2023 and December 31, 2022; issued and outstanding: 56,343,164 and 56,133,404 shares as of March 31, 2023 and December 31, 2022, respectively		6			6
Additional paid-in capital		1,545,777			1,505,632
Accumulated other comprehensive loss		(77,204	)		(73,109	)
Retained earnings		882,215			743,837
Total stockholders’ equity		2,350,794			2,176,366
Total liabilities and stockholders’ equity	$	4,496,426		$	4,265,949

The accompanying notes are an integral part of the condensed consolidated financial statements.

F -  2

SOLAREDGE TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

(in thousands, except per share data)

	Three Months Ended March 31,
	2023			2022
Revenues	$	943,889		$	655,080
Cost of revenues		643,763			476,122
Gross profit		300,126			178,958
Operating expenses:
Research and development		79,873			66,349
Sales and marketing		40,966			35,316
General and administrative		36,567			26,429
Other operating income, net		(1,434	)		-
Total operating expenses		155,972			128,094
Operating income		144,154			50,864
Financial income (expense), net		23,674			(4,605	)
Other loss		(125	)		(844	)
Income before income taxes		167,703			45,415
Income taxes		29,325			12,292
Net income	$	138,378		$	33,123
Net basic earnings per share of common stock	$	2.46		$	0.62
Net diluted earnings per share of common stock	$	2.35		$	0.60
Weighted average number of shares used in computing net basic earnings per share of common stock		56,215,490			53,134,937
Weighted average number of shares used in computing net diluted earnings per share of common stock		59,193,831			56,315,193

The accompanying notes are an integral part of the condensed consolidated financial statements.

F -  3

SOLAREDGE TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(in thousands, except per share data)

	Three Months Ended March 31,
	2023			2022
Net income	$	138,378		$	33,123
Other comprehensive income (loss), net of tax:
Available-for-sale marketable securities		6,177			(9,506	)
Cash flow hedges		(331	)		(680	)
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment nature		(10,800	)		(6,983	)
Foreign currency translation adjustments		859			(1,579	)
Total other comprehensive loss		(4,095	)		(18,748	)
Comprehensive income	$	134,283		$	14,375

The accompanying notes are an integral part of the condensed consolidated financial statements.

F -  4

SOLAREDGE TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited)

(in thousands, except per share data)

	Common stock				Additional paid in Capital		Accumulated other comprehensive loss			Retained earnings		Total
	Number		Amount
Balance as of January 1, 2023		56,133,404	$	6	$	1,505,632	$	(73,109	)	$	743,837	$	2,176,366
Issuance of common stock upon exercise of stock-based awards		209,760		*-		75		-			-		75
Stock based compensation		-		-		40,070		-			-		40,070
Other comprehensive loss adjustments		-		-		-		(4,095	)		-		(4,095	)
Net income		-		-		-		-			138,378		138,378
Balance as of March 31, 2023	$	56,343,164	$	6	$	1,545,777	$	(77,204	)	$	882,215	$	2,350,794

* Represents an amount less than $1.

	Common stock				Additional paid in Capital		Accumulated other comprehensive income (loss)			Retained earnings		Total
	Number		Amount
Balance as of January 1, 2022		52,815,395	$	5	$	687,295	$	(27,319	)	$	650,058	$	1,310,039
Issuance of common stock upon exercise of stock-based awards		270,751		*-		1,478		-			-		1,478
Stock based compensation		-		-		34,107		-			-		34,107
Issuance of common stock in a secondary public offering, net of underwriters' discounts and commissions of $27,140 and $834 of offering costs		2,300,000		1		650,525		-			-		650,526
Other comprehensive loss adjustments		-		-		-		(18,748	)		-		(18,748	)
Net income		-		-		-		-			33,123		33,123
Balance as of March 31, 2022		55,386,146	$	6	$	1,373,405	$	(46,067	)	$	683,181	$	2,010,525

* Represents an amount less than $1.

The accompanying notes are an integral part of the condensed consolidated financial statements.

F -  5

SOLAREDGE TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in thousands, except per share data)

	Three Months Ended March 31,
	2023			2022
Cash flows from operating activities:
Net income	$	138,378		$	33,123
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization		13,464			11,660
Stock-based compensation expenses		39,235			34,107
Deferred income taxes, net		(3,930	)		(1,034	)
Loss (gain) from exchange rate fluctuations		(20,441	)		1,725
Other items		2,810			4,167
Changes in assets and liabilities:
Inventories, net		(141,521	)		(51,323	)
Prepaid expenses and other assets		(20,591	)		(17,163	)
Trade receivables, net		(55,002	)		(224,865	)
Trade payables, net		(50,410	)		(28,045	)
Employees and payroll accruals		10,227			9,246
Warranty obligations		57,864			27,629
Deferred revenues and customers advances		9,325			15,029
Accrued expenses and other liabilities, net		28,515			22,755
Net cash provided by (used in) operating activities		7,923			(162,989	)
Cash flows from investing activities:
Proceed from sales and maturities of available-for-sale marketable securities		11,597			53,096
Purchase of property, plant and equipment		(38,338	)		(43,210	)
Investment in available-for-sale marketable securities		(38,979	)		(26,712	)
Investment in a privately-held company		(5,500	)		-
Other investing activities		3,440			1,692
Net cash used in investing activities	$	(67,780	)	$	(15,134	)

The accompanying notes are an integral part of the condensed consolidated financial statements.

F -  6

SOLAREDGE TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Cont.)

(in thousands, except per share data)

	Three Months Ended March 31,
	2023			2022
Cash flows from financing activities:
Proceeds from secondary public offering, net of issuance costs	$	-		$	650,526
Proceeds from exercise of stock-based awards		75			1,478
Tax withholding in connection with stock-based awards, net		(4,541	)		822
Other financing activities		(756	)		(491	)
Net cash provided by (used in) financing activities		(5,222	)		652,335
Increase (decrease) in cash and cash equivalents		(65,079	)		474,212
Cash and cash equivalents at the beginning of the period		783,112			530,089
Effect of exchange rate differences on cash and cash equivalents		9,816			(1,529	)
Cash and cash equivalents at the end of the period	$	727,849		$	1,002,772
Supplemental disclosure of non-cash activities:
Right-of-use asset recognized with a corresponding lease liability	$	11,258		$	27,248
Purchase of property, plant and equipment	$	12,304		$	19,536

The accompanying notes are an integral part of the condensed consolidated financial statements.

 F - 7

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands, except per share data)

NOTE 1:      GENERAL

a. SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughput from each and every module through constant tracking of Maximum Power Point individually per module, (ii) inverters which invert direct current (DC) from the PV module to alternating current (AC) including the Company’s Energy Hub inverter which supports, among other things, connection to a DC-coupled battery for full or partial home backup, and optional connection to the Company's smart EV charger, (iii) a remote cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters to enable customers and system owners, to monitor and manage the solar PV system (iv) a residential storage and backup solution which includes a company designed and manufactured lithium-ion DC-coupled battery that is used to increase energy independence and maximize self-consumption for homeowners including a battery, and (v) additional smart energy management solutions.

The Company and its subsidiaries sell products worldwide through large distributors, electrical equipment wholesalers, as well as directly to large solar installers and engineering, procurement, and construction firms.

b. The Company has expanded its activity to other areas of smart energy technology organically and through acquisitions. The Company now offers a variety of energy solutions, which include lithium-ion cells, batteries, and energy storage systems (“Energy Storage”), full powertrain kits for electric vehicles, or EVs (“e-Mobility”), as well as automated machines for industrial use (“Automation Machines”).

c. Basis of Presentation:

The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. The Company’s interim period results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year.

The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2022, contained in the Company’s Annual Report on Form 10-K filed with the SEC on February 22, 2023, have been applied consistently in these unaudited interim condensed consolidated financial statements. Certain prior year amounts have been reclassified to conform to current year presentation.

d. Use of estimates:

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes. The duration, scope and effects of the ongoing Covid-19 pandemic and the conflict in Ukraine, government and other third-party responses to it, and the related macroeconomic effects, including to the Company’s business and the business of the Company’s suppliers and customers are uncertain, rapidly changing and difficult to predict. As a result, the Company’s accounting estimates and assumptions may change over time in response to this evolving situation. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, inventories, incremental credit losses on receivables and available-for-sale marketable debt securities, or an increase in the Company’s insurance liabilities as of the time of a relevant measurement event.

e. Concentrations of supply risks:

The Company depends on two contract manufacturers and several limited or single source component suppliers. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields, and costs.

As of March 31, 2023, and December 31, 2022, two contract manufacturers collectively accounted for 31.3% and 34.3% of the Company’s total trade payables, net, respectively.

In the second quarter of 2022, the Company announced the opening of “Sella 2”, a two gigawatt-hour (GWh) Li-Ion battery cell manufacturing facility located in South Korea. Sella 2 began producing and shipping cells at the end of 2022 and is expected to reach full manufacturing capacity in 2023. Sella 2 is the Company's second owned manufacturing facility following the establishment of Sella 1 in 2020. Sella 1 is the Company's manufacturing facility in the North of Israel that produces power optimizers and inverters for the Company's solar activities.

f. New accounting standards updates:

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") or other standard setting bodies are adopted by the Company as of the specified effective date. The Company believes that the impact of recently issued or newly effective standards were not applicable to the Company, did not have a material impact on the condensed consolidated financial statements or are not expected to have a material impact on the condensed consolidated financial statements.

F - 8

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

NOTE 2:       MARKETABLE SECURITIES

The following is a summary of available-for-sale marketable securities as of March 31, 2023:

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale – matures within one year:
Corporate bonds	$	390,012	$	82	$	(8,595	)	$	381,499
Governmental bonds		29,788		-		(467	)		29,321
		419,800		82		(9,062	)		410,820
Available-for-sale – matures after one year:
Corporate bonds		515,425		698		(15,855	)		500,268
Governmental bonds		9,251		-		(392	)		8,859
		524,676		698		(16,247	)		509,127
Total	$	944,476	$	780	$	(25,309	)	$	919,947

The following is a summary of available-for-sale marketable securities as of December 31, 2022:

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale – matures within one year:
Corporate bonds	$	222,482	$	-	$	(4,657	)	$	217,825
Governmental bonds		23,845		-		(553	)		23,292
		246,327		-		(5,210	)		241,117
Available-for-sale – matures after one year:
Corporate bonds		657,238		80		(26,460	)		630,858
Governmental bonds		15,250		-		(617	)		14,633
		672,488		80		(27,077	)		645,491
Total	$	918,815	$	80	$	(32,287	)	$	886,608

As of March 31, 2023, and December 31, 2022, the Company did not record an allowance for credit losses for its available-for-sale marketable securities.

F - 9

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

NOTE 3:       INVENTORIES, NET

	March 31, 2023		December 31, 2022
Raw materials	$	503,445	$	503,257
Work in process		37,754		23,407
Finished goods		333,013		202,537
Total inventories, net	$	874,212	$	729,201

NOTE 4:       PREPAID EXPENSES AND OTHER CURRENT ASSETS

	March 31, 2023		December 31, 2022
Vendor non-trade receivables (*)	$	147,238	$	147,597
Government authorities		57,275		55,670
Prepaid expenses and other		55,129		37,815
Total prepaid expenses and other current assets	$	259,642	$	241,082

(*) Vendor non-trade receivables derived from the sale of components to manufacturing vendors who manufacture products for the Company. The Company purchases these components directly from other suppliers. The Company does not reflect the sale of these components to the contract manufacturers in its revenues.

F - 10

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

NOTE 5:       DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

During the three months ended March 31, 2023, the Company instituted a foreign currency cash flow hedging program to reduce the risk of a forecasted increase in the value of foreign currency cash flows, resulting from payment of salaries in Israeli currency, the New Israeli Shekels (“NIS”). The Company hedges portions of the anticipated payroll denominated in NIS for a period of one to nine months with hedging contracts. These hedging contracts are designated as cash flow hedges, as defined by ASC 815 and are all effective hedges.

As of March 31, 2023, the Company entered into forward contracts and put and call options to sell U.S. dollars (“USD”) for NIS in the amount of approximately NIS 231 million and NIS 125 million, respectively.

In addition to the above-mentioned cash flow hedge transactions, the Company occasionally enters into derivative instrument arrangements to hedge the Company’s exposure to currencies other than the USD. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the statement of income, under "Financial income (expense), net".

The Company classifies cash flows related to its hedging as operating activities in its condensed consolidated statement of cash flows.

The fair values of outstanding derivative instruments were as follows:

	Balance sheet location	March 31, 2023			December 31, 2022
Derivative assets of options and forward contracts:
Designated cash flow hedges	Prepaid expenses and other current assets	$	353		$	-
Derivative liabilities of options and forward contracts:
Designated cash flow hedges	Accrued expenses and other current liabilities	$	(2,583	)	$	(1,874	)

Gains (losses) on derivative instruments are summarized below:

		Three Months Ended March 31,
	Affected line item	2023			2022
Foreign exchange contracts
Non Designated Hedging Instruments	Condensed Consolidated Statements of Income - Financial income (expense), net	$	-		$	934
Designated Hedging Instruments	Condensed Consolidated Statements of Comprehensive Income - Cash flow hedges	$	(2,057	)	$	(1,178	)

See Note 13 for information regarding losses from designated hedging instruments reclassified from accumulated other comprehensive loss.

F - 11

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

NOTE 6:    FAIR VALUE MEASUREMENTS

In accordance with ASC 820, the Company measures its cash equivalents and marketable securities, at fair value using the market approach valuation technique. Cash and cash equivalents are classified within Level 1 because these assets are valued using quoted market prices. Marketable securities and foreign currency derivative contracts are classified within level 2 due to these assets being valued by alternative pricing sources and models utilizing market observable inputs.

The following table sets forth the Company’s assets that were measured at fair value as of March 31, 2023 and December 31, 2022, by level within the fair value hierarchy:

	Fair Value Hierarchy	Fair value measurements as of
Description		March 31, 2023			December 31, 2022
Assets:
Cash and cash equivalents:
Cash	Level 1	$	667,384		$	695,004
Money market mutual funds	Level 1	$	17,486		$	25,149
Deposits	Level 1	$	42,979		$	62,959
Derivative instruments	Level 2	$	353		$	-
Short-term marketable securities:
Corporate bonds	Level 2	$	381,499		$	217,825
Governmental bonds	Level 2	$	29,321		$	23,292
Long-term marketable securities:
Corporate bonds	Level 2	$	500,268		$	630,858
Governmental bonds	Level 2	$	8,859		$	14,633
Liabilities:
Derivative instruments	Level 2	$	(2,583	)	$	(1,874	)

NOTE 7:       WARRANTY OBLIGATIONS

Changes in the Company’s product warranty obligations for the three months ended March 31, 2023 and 2022, were as follows:

	Three Months Ended March 31,
	2023			2022
Balance, at the beginning of the period	$	385,057		$	265,160
Additions and adjustments to cost of revenues		91,570			47,907
Usage and current warranty expenses		(33,656	)		(20,401	)
Balance, at end of the period		442,971			292,666
Less current portion		(129,278	)		(82,340	)
Long term portion	$	313,693		$	210,326

F - 12

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

NOTE 8:       DEFERRED REVENUES AND CUSTOMERS ADVANCES

Deferred revenues consist of deferred cloud-based monitoring services, communication services, warranty extension services and advance payments received from customers for the Company’s products. Deferred revenues are classified as short-term and long-term deferred revenues based on the period in which revenues are expected to be recognized.

Significant changes in the balances of deferred revenues and customer advances during the period are as follows:

	Three Months Ended March 31,
	2023			2022
Balance, at the beginning of the period	$	213,577		$	169,345
Revenue recognized		(11,742	)		(14,529	)
Increase in deferred revenues and customer advances		22,589			29,429
Balance, at the end of the period		224,424			184,245
Less current portion		(27,507	)		(25,511	)
Long term portion	$	196,917		$	158,734

The following table includes estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) as of March 31, 2023:

2023	$	23,888
2024		12,073
2025		10,764
2026		10,389
2027		8,363
Thereafter		158,947
Total deferred revenues	$	224,424

NOTE 9:       ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

	March 31, 2023		December 31, 2022
Accrued expenses	$	127,018	$	117,638
Government authorities		87,159		67,514
Operating lease liabilities		17,215		16,183
Accrual for sales incentives		5,746		6,790
Other		6,743		5,987
Total accrued expenses and other current liabilities	$	243,881	$	214,112

F - 13

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

NOTE 10:       CONVERTIBLE SENIOR NOTES

On September 25, 2020, the Company sold $632,500 aggregate principal amount of its 0.00% convertible senior notes due 2025 (the “Notes”). The Notes were sold pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes do not bear regular interest and mature on September 15, 2025, unless earlier repurchased or converted in accordance with their terms. The Notes are general senior unsecured obligations of the Company. Holders may convert their Notes prior to the close of business on the business day immediately preceding June 15, 2025 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2020 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five-business-day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each trading day of that five consecutive trading day period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events as described in the Indenture. In addition, holders may convert their Notes, in multiples of $1,000 principal amount, at their option at any time beginning on or after June 15, 2025, and prior to the close of business on the second scheduled trading day immediately preceding the stated maturity date of the Notes, without regard to the foregoing circumstances. The initial conversion rate for the Notes was 3.5997 shares of common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $277.80 per share of common stock, subject to adjustment upon the occurrence of certain specified events as set forth in the Indenture.

Upon conversion, the Company may choose to pay or deliver, as the case may be, cash, shares of common stock, or a combination of cash and shares of common stock.

In addition, upon the occurrence of a fundamental change (as defined in the Indenture), holders of the Notes may require the Company to repurchase all or a portion of their Notes, in multiples of $1,000 principal amount, at a repurchase price of 100% of the principal amount of the Notes, plus any accrued and unpaid special interest to, but excluding the fundamental change repurchase date. If certain fundamental changes referred to as make-whole fundamental changes occur, the conversion rate for the Notes may be increased.

The Convertible Senior Notes consisted of the following as of March 31, 2023 and December 31, 2022:

	March 31, 2023			December 31, 2022
Liability:
Principal	$	632,500		$	632,500
Unamortized issuance costs		(7,318	)		(8,049	)
Net carrying amount	$	625,182		$	624,451

For the three months ended March 31, 2023 and 2022 the Company recorded amortized debt issuance costs related to the Notes in the amount of $731 and $728, respectively.

As of March 31, 2023, the unamortized issuance costs of the Notes will be amortized over the remaining term of approximately 2.5 years.

The annual effective interest rate of the Notes is 0.47%.

As of March 31, 2023, the estimated fair value of the Notes, which the Company has classified as Level 2 financial instruments, is $823,730. The estimated fair value was determined based on the quoted bid price of the Notes in an over-the-counter market on the last trading day of the reporting period.

As of March 31, 2023, the if-converted value of the Notes exceeded the principal amount by $59,537.

F - 14

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

NOTE 11:       STOCK CAPITAL

a. Common stock rights:

Common stock confers upon its holders the right to receive notice of, and to participate in, all general meetings of the Company, where each share of common stock shall have one vote for all purposes, to share equally, on a per share basis, in bonuses, profits, or distributions out of fund legally available therefor, and to participate in the distribution of the surplus assets of the Company in the event of liquidation of the Company.

b. Secondary public offering:

On March 17, 2022, the Company offered and sold 2,300,000 shares of the Company’s common stock, at a public offering price of $295.00 per share. The shares of Common Stock were issued and sold in a registered offering pursuant to the underwriting agreement dated March 17, 2022, among the Company, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Morgan Stanley & Co. LLC (the “Underwriting Agreement”). All of the offered shares were issued at closing, including 300,000 shares of Common Stock that were issued and sold pursuant to the underwriters’ option to purchase additional shares under the Underwriting Agreement, which was exercised in full on March 18, 2022.

The net proceeds to the Company were $650,526 after deducting underwriters' discounts of $27,140 and commissions of $834.

c. Equity Incentive Plans:

The Company’s 2007 Global Incentive Plan (the “2007 Plan”) was adopted by the board of directors on August 30, 2007. The 2007 Plan terminated upon the Company’s IPO on March 31, 2015 and no further awards may be granted thereunder. All outstanding awards will continue to be governed by their existing terms and 379,358 available options for future grants were transferred to the Company’s 2015 Global Incentive Plan (the “2015 Plan”) and are reserved for future issuances under the 2015 plan. The 2015 Plan became effective upon the consummation of the IPO. The 2015 Plan provides for the grant of options, restricted stock units ("RSU"), performance stock units ("PSU"), and other share-based awards to directors, employees, officers, and non-employees of the Company and its subsidiaries. As of March 31, 2023, a total of 20,853,755 shares of common stock were reserved for issuance pursuant to stock awards under the 2015 Plan (the “Share Reserve”), an aggregate of 12,005,195 shares are still available for future grants.

The Share Reserve will automatically increase on January 1^st of each year during the term of the 2015 Plan, commencing on January 1^st  of the year following the year in which the 2015 Plan becomes effective, in an amount equal to 5% of the total number of shares of capital stock outstanding on December 31^st of the preceding calendar year; provided, however, that the Company’s board of directors may determine that there will not be a January 1^st increase in the Share Reserve in a given year or that the increase will be less than 5% of the shares of capital stock outstanding on the preceding December 31^st.

The Company granted under its 2015 Plan, PSU awards to certain employees and officers which vest upon the achievement of certain performance or market conditions subject to their continued employment with the Company.

In 2021, the Company has also committed to issuing additional shares, which carry certain performance conditions (including business performance targets and a continued service relationship with the Company) and are treated as PSUs for accounting purposes.
 

The market condition for the PSUs is based on the Company’s total shareholder return ("TSR") compared to the TSR of companies listed in the S&P 500 index over a one to three year performance period. The Company uses a Monte-Carlo simulation to determine the grant date fair value for these awards, which takes into consideration the market price of a share of the Company’s common stock on the date of grant less the present value of dividends expected during the requisite service period, as well as the possible outcomes pertaining to the TSR market condition. The Company recognizes such compensation expenses on an accelerated vesting method.

The aggregate maximum number of shares of common stock that may be issued on the exercise of incentive stock options is 10,000,000. As of March 31, 2023, an aggregate of 8,617,974 options are still available for future grants under the 2015 Plan.

F - 15

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

A summary of the activity in stock options and related information is as follows:

	Number of options			Weighted average exercise price		Weighted average remaining contractual term in years		Aggregate intrinsic Value
Outstanding as of December 31, 2022		339,029		$	50.64		4.86	$	79,414
Exercised		(3,645	)		20.46		-		1,073
Outstanding as of March 31, 2023		335,384		$	50.97		4.63	$	84,989
Vested and expected to vest as of March 31, 2023		334,950		$	50.80		4.62	$	84,937
Exercisable as of March 31, 2023		311,240		$	40.47		4.43	$	82,079

The aggregate intrinsic value in the tables above represents the total intrinsic value (the difference between the fair value of the Company’s common stock as of the last day of each period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last day of each period.

A summary of the activity in the RSUs and related information is as follows:

	Number of RSUs			Weighted average grant date fair value
Unvested as of December 31, 2022		1,488,515		$	232.05
Granted		103,081			296.64
Vested		(197,866	)		164.31
Forfeited		(31,296	)		254.24
Unvested as of March 31, 2023		1,362,434		$	246.27

A summary of the activity in the PSUs and related information is as follows:

	Number of PSUs			Weighted average grant date fair value
Unvested as of December 31, 2022		149,232		$	295.88
Granted		31,911			314.22
Vested		(8,249	)		270.93
Unvested as of March 31, 2023		172,894		$	300.45

d. Employee Stock Purchase Plan ("ESPP"):

The Company adopted an ESPP effective upon the consummation of the IPO. As of March 31, 2023, a total of 4,150,380 shares were reserved for issuance under this plan. The number of shares of common stock reserved for issuance under the ESPP will increase automatically on January 1^st of each year, for ten years, by the lesser of 1% of the total number of shares of the Company’s common stock outstanding on December 31st of the preceding calendar year or 487,643 shares. However, the Company’s board of directors may reduce the amount of the increase in any particular year at their discretion, including a reduction to zero.

The ESPP is implemented through an offering every six months. According to the ESPP, eligible employees may use up to 15% of their salaries to purchase common stock up to an aggregate limit of $15 per participant for every six months plan. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the subscription date of each offering period or on the purchase date.

As of March 31, 2023, 738,876 shares of common stock had been purchased under the ESPP.

As of March 31, 2023, 3,411,504 shares of common stock were available for future issuance under the ESPP.

In accordance with ASC No. 718, the ESPP is compensatory and, as such, results in recognition of compensation cost.

F - 16

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

e. Stock-based compensation expenses:

The Company recognized stock-based compensation expenses related to all stock-based awards in the condensed consolidated statement of income for the three months ended March 31, 2023, and 2022, as follows:

	Three Months Ended March 31,
	2023		2022
Cost of revenues	$	5,927	$	5,062
Research and development		17,209		14,985
Selling and marketing		8,079		6,701
General and administrative		8,020		7,359
Total stock-based compensation expenses	$	39,235	$	34,107

For the three months ended March 31, 2023, the Company capitalized stock-based compensation expenses in the amount of $430 related to ERP implementation, which were included within other long-term assets in the condensed consolidated balance sheets and $405 related to inventory.

For the three months ended March 31, 2022, the Company did not capitalize any stock-based compensation expenses.

The total tax benefit associated with share-based compensation for the three months ended March 31, 2023 and 2022 was $4,197 and $3,478, respectively. The tax benefit realized from share-based compensation for three months ended March 31, 2023 and 2022 was $2,842 and $2,927, respectively.

As of March 31, 2023, there were total unrecognized compensation expenses in the amount of $335,864 related to non-vested equity-based compensation arrangements granted. These expenses are expected to be recognized during the period from April 1, 2023 through February 28, 2027.

F - 17

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

NOTE 12:     COMMITMENTS AND CONTINGENT LIABILITIES

a. Guarantees:

As of March 31, 2023, contingent liabilities exist regarding guarantees in the amounts of $5,876, and $1,899 in respect of office rent lease agreements and customs and other transactions, respectively.

b. Contractual purchase obligations:

The Company has contractual obligations to purchase goods and raw materials. These contractual purchase obligations relate to inventories and other purchase orders, which cannot be canceled without penalty. In addition, the Company acquires raw materials or other goods and services, including product components, by issuing authorizations to its suppliers to purchase materials based on its projected demand and manufacturing needs.

As of March 31, 2023, the Company had non-cancelable purchase obligations totaling approximately $1,617,376, out of which the Company recorded a provision for loss in the amount of $8,052.

As of March 31, 2023, the Company had contractual obligations for capital expenditures totaling approximately $121,347. These commitments reflect purchases of automated assembly lines and other machinery related to the Company’s general manufacturing process and mainly to its plans to establish manufacturing capabilities in the United States.

c.  Legal claims:

From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular matter.

In September 2018, the Company’s German subsidiary, SolarEdge Technologies GmbH, received a complaint filed by competitor SMA Solar Technology AG (“SMA”). The complaint, filed in the District Court Düsseldorf, Germany, alleges that SolarEdge's 12.5kW - 27.6kW inverters infringed on two of the plaintiff’s patents. SMA asserted a value in dispute of EUR 5.5 million (approximately $5,983) for both patents. The Company challenged the validity of both patents and the first patent was invalidated and SMA’s appeal on the matter was denied in January 2023. In August 2021, the German Patent Court rendered SMA's second patent invalid, and this invalidity has been appealed by SMA and a hearing is pending. The Company believes that it has meritorious defenses to these claims and intends to vigorously defend against the remaining lawsuit.

On July 28, 2022, the Company was served with complaints filed by Ampt LLC in the International Trade Commission (the “Commission”) pursuant to Section 337 of the Tariff Act of 1930, as amended, in the District Court for the District of Delaware alleging patent infringement against the Company and its subsidiary SolarEdge Technologies Ltd. On October 24, 2022, the complaint filed in the District Court of Delaware was administratively stayed until the Commission's action is resolved. The Company believes that it has meritorious defenses to the complaints and intend to vigorously defend against them.

As of March 31, 2023, an immaterial amount for legal claims was recorded in accrued expenses and other current liabilities.

F - 18

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

NOTE 13:       ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table summarizes the changes in accumulated balances of other comprehensive gain (loss), net of taxes:

	Three Months Ended March 31,
	2023			2022
Unrealized gains (losses) on available-for-sale marketable securities
Beginning balance	$	(25,449	)	$	(4,709	)
Revaluation		7,570			(12,721	)
Tax on revaluation		(1,471	)		2,471
Other comprehensive income (loss) before reclassifications		6,099			(10,250	)
Reclassification		107			844
Tax on reclassification		(29	)		(100	)
Losses reclassified from accumulated other comprehensive income		78			744
Net current period other comprehensive income (loss)		6,177			(9,506	)
Ending balance	$	(19,272	)	$	(14,215	)
Unrealized gains (losses) on cash flow hedges
Beginning balance	$	(1,761	)	$	874
Revaluation		(2,196	)		(1,337	)
Tax on revaluation		139			159
Other comprehensive loss before reclassifications		(2,057	)		(1,178	)
Reclassification		1,840			565
Tax on reclassification		(114	)		(67	)
Losses reclassified from accumulated other comprehensive loss		1,726			498
Net current period other comprehensive loss		(331	)		(680	)
Ending balance	$	(2,092	)	$	194
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment in nature
Beginning balance	$	(37,960	)	$	(17,420	)
Revaluation		(10,800	)		(6,983	)
Ending balance	$	(48,760	)	$	(24,403	)
Unrealized gains (losses) on foreign currency translation
Beginning balance	$	(7,939	)	$	(6,064	)
Revaluation		859			(1,579	)
Ending balance	$	(7,080	)	$	(7,643	)
Total	$	(77,204	)	$	(46,067	)

F - 19

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

The following table summarizes the reclassifications from "Accumulated other comprehensive loss" into the statement of income:

Details about Accumulated Other Comprehensive Loss Components	Three Months Ended March 31,						Affected Line Item in the Statement of Income
	2023			2022
Available-for-sale marketable securities
	$	(107	)	$	(844)		Financial income (expense), net
		29			100		Income taxes
	$	(78	)	$	(744)		Total, net of income taxes
Cash flow hedges
		(212	)		(67	)	Cost of revenues
		(1,129	)		(338	)	Research and development
		(225	)		(71	)	Sales and marketing
		(274	)		(89	)	General and administrative
	$	(1,840	)	$	(565)		Total, before income taxes
		114			67		Income taxes
		(1,726	)		(498	)	Total, net of income taxes
Total reclassifications for the period	$	(1,804	)	$	(1,242)

NOTE 14:       OTHER OPERATING INCOME

In the three months ended March 31, 2023, the Company recorded a gain from sale of property, plant and equipment and other assets in the amount of $1,434.

NOTE 15:       INCOME TAXES

The effective tax rate for the three months ended March 31, 2023, and 2022 was 17.5% and 27.1%, respectively.

The lower tax rate in the current quarter compared to the first quarter of 2022 is mainly due to the fact that the Company's income before tax, most of which is subject to tax rates lower than the US statutory rate, increased. Conversely, the IRC Section 174 R&D capitalization, and other expenses not recognized for GILTI purposes, did not increase in the same proportion.

As of March 31, 2023, and December 31, 2022, unrecognized tax benefits were $2,883 and $2,756, respectively. If recognized, such benefits would favorably affect the Company’s effective tax rate.

The Company accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes. The total amount of penalties and interest were immaterial as of March 31, 2023, and December 31, 2022.

In August 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the “IRA”), which includes several incentives intended to promote clean energy, battery and energy storage, electrical vehicles, and other solar products, and is expected to impact our business and operations. As part of such incentives the IRA, will among other things, extend the investment tax credit (“ITC”) through 2034 and is therefore expected to increase the demand for solar products. The IRA is expected to further incentivize residential and commercial solar customers and developers due to the inclusion of a tax credit for qualifying energy projects of up to 30%. Since these regulations are new and their implementation is still pending administrative guidance from the Internal Revenue Service and U.S. Treasury Department, the Company will be examining the benefits that may be available to it, such as the availability of tax credits for domestic manufacturers, in the coming months. The Company also announced its plans to establish manufacturing capabilities in the United States during 2023.

F - 20

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

NOTE 16:       EARNINGS PER SHARE

The following table presents the computation of basic and diluted earnings per share (“EPS”):

	Three Months Ended March 31,
	2023		2022
Basic EPS:
Numerator:
Net income	$	138,378	$	33,123
Denominator:
Shares used in computing net earnings per share of common stock, basic		56,215,490		53,134,937
Diluted EPS:
Numerator:
Net income attributable to common stock, basic	$	138,378	$	33,123
Notes due 2025		552		553
Net income attributable to common stock, diluted	$	138,930	$	33,676
Denominator:
Shares used in computing net earnings per share of common stock, basic		56,215,490		53,134,937
Notes due 2025		2,276,818		2,276,818
Effect of stock-based awards		701,523		903,438
Shares used in computing net earnings per share of common stock, diluted		59,193,831		56,315,193
Earnings per share:
Basic	$	2.46	$	0.62
Diluted	$	2.35	$	0.60
Shares excluded from the calculation of diluted net EPS due to their anti-dilutive effect		192,339		223,776

F - 21

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

NOTE 17:      SEGMENT INFORMATION

Following the discontinuation of Critical Power in June 2022, the Company operates in four different operating segments: Solar, Energy Storage, e-Mobility and Automation Machines.

The Company’s Chief Executive Officer, who is the chief operating decision maker (“CODM”), makes resource allocation decisions and assesses performance based on financial information presented on a consolidated basis, accompanied by disaggregated information about revenues and contributed profit by the operating segments.

The Company does not allocate to its operating segments revenue recognized due to advance payments received for performance obligations that extend for a period greater than one year, related to Accounting Standard Codification 606, “Revenue from Contracts with Customers” (ASC 606).

Segment profit is comprised of gross profit for the segment less operating expenses that do not include amortization of purchased intangible assets, impairments of goodwill and intangible assets, stock based compensation expenses, and certain other items.

The Company manages its assets on a group basis, not by segments, as many of its assets are shared or co-mingled. The Company’s CODM does not regularly review asset information by segments and, therefore, the Company does not report asset information by segment.

The Company identified one operating segment as reportable – the Solar segment. The other operating segments are insignificant individually and therefore their results are presented together under “All other”.

The Solar segment includes the design, development, manufacturing, and sales of an intelligent inverter solution designed to maximize power generation at the individual PV module level and a residential storage solution, compatible with the Company’s Energy Hub inverter, intended to store and supply power for back-up and to maximize self-consumption. The Solar segment solution consists mainly of the Company’s power optimizers, inverters, batteries, and cloud‑based monitoring platform.

The “All other” category includes the design, development, manufacturing, and sales of energy storage products, e-Mobility products, UPS products, and automated machines.

F - 22

SOLAREDGE TECHNOLOGIES INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

(in thousands, except per share data)

The following table presents information on reportable segments profit (loss) for the period presented:

	Three Months Ended March 31,
	2023					2022
	Solar		All other			Solar		All other
Revenues	$	908,505	$	35,197		$	607,997	$	46,948
Cost of revenues		590,105		46,216			424,500		44,341
Gross profit (loss)		318,400		(11,019	)		183,497		2,607
Research and development	$	55,823	$	6,528		$	43,131	$	7,930
Sales and marketing		31,145		1,561			25,805		2,574
General and administrative		24,743		3,778			15,849		3,625
Segments profit (loss)	$	206,689	$	(22,886	)	$	98,712	$	(11,522	)

The following table presents information on reportable segments reconciliation to consolidated revenues for the periods presented:

	Three Months Ended March 31,
	2023		2022
Solar revenues	$	908,505	$	607,997
All other segment revenues		35,197		46,948
Revenues from financing component		187		135
Consolidated revenues	$	943,889	$	655,080

The following table presents information on reportable segments reconciliation to consolidated operating income for the periods presented:

	Three Months Ended March 31,
	2023			2022
Solar segment profit	$	206,689		$	98,712
All other segment loss		(22,886	)		(11,522	)
Segments operating profit		183,803			87,190
Amounts not allocated to segments:
Stock based compensation expenses		(39,235	)		(34,107	)
Other unallocated expenses		(414	)		(2,219	)
Consolidated operating income	$	144,154		$	50,864

NOTE 18:      SUBSEQUENT EVENTS

On April 6, 2023, the Company completed the acquisition of all outstanding shares of Hark Systems Ltd. ("Hark"), a UK-based energy IoT company for the commercial and industrial ("C&I") sector for approximately USD 16.7 million in cash. Hark's platform is expected to enable the Company to offer its commercial and industrial customers expanded capabilities in energy management and connectivity, including identification of potential energy savings, detection of anomalies in assets’ energy consumption, and optimization of energy usage and carbon emissions through load orchestration and storage control.

F - 23

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Statements contained in this Form 10-Q or statements incorporated by reference from documents we have filed with the Securities and Exchange Commission may contain forward-looking statements that are based on our management’s expectations, estimates, projections, beliefs and assumptions in accordance with information currently available to our management. Forward-looking statements should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in Part 1, Item 1 of this report. This discussion contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, technology developments, new products and services, financing and investment plans, competitive position, industry and regulatory environment, effects of acquisitions, growth opportunities and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipate,” “believe,” “could,” “seek,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or similar expressions and the negatives of those terms.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Given these uncertainties, you should not place undue reliance on forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this filing. Important factors that could cause actual results to differ materially from our expectations include:

• future demand for renewable energy including solar energy solutions;

• changes to net metering policies or the reduction, elimination or expiration of government subsidies and economic incentives for on-grid solar energy applications;

• changes in the U.S. trade environment, including the imposition of import tariffs;

• federal, state, and local regulations governing the electric utility industry with respect to solar energy;

• changes in tax laws, tax treaties, and regulations or the interpretation of them, including the Inflation Reduction Act;

• the retail price of electricity derived from the utility grid or alternative energy sources;

• interest rates and supply of capital in the global financial markets in general and in the solar market specifically;

• competition, including introductions of power optimizer, inverter and solar photovoltaic (“PV”) system monitoring products by our competitors;

• developments in alternative technologies or improvements in distributed solar energy generation;

• historic cyclicality of the solar industry and periodic downturns;

• product quality or performance problems in our products;

• our ability to forecast demand for our products accurately and to match production with demand;

• our dependence on ocean transportation to timely deliver our products in a cost-effective manner;

• our dependence upon a small number of outside contract manufacturers and limited or single source suppliers;

• capacity constraints, delivery schedules, manufacturing yields, and costs of our contract manufacturers and availability of components;

• delays, disruptions, and quality control problems in manufacturing;

• shortages, delays, price changes, or cessation of operations or production affecting our suppliers of key components;

3

• existing and future responses to and effects of Covid-19;

• business practices and regulatory compliance of our raw material suppliers;

• performance of distributors and large installers in selling our products;

• disruption in our global supply chain and rising prices of oil and raw materials as a result of the conflict between Russia and Ukraine may adversely affect our business;

• our customers’ financial stability, creditworthiness, and debt leverage ratio;

• our ability to retain key personnel and attract additional qualified personnel;

• our ability to effectively design, launch, market, and sell new generations of our products and services;

• our ability to maintain our brand and to protect and defend our intellectual property;

• our ability to retain, and events affecting, our major customers;

• our ability to manage effectively the growth of our organization and expansion into new markets;

• our ability to integrate acquired businesses;

• fluctuations in global currency exchange rates;

• unrest, terrorism, or armed conflict in Israel;

• macroeconomic conditions in our domestic and international markets, as well as inflation concerns, financial institutions instability, rising interest rates and recessionary concerns;

• consolidation in the solar industry among our customers and distributors;

• our ability to service our debt; and

• the other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent reports on Form 10-Q and in other documents we file from time to time with the SEC that disclose risks and uncertainties that may affect our business.

The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Overview

We are a leading provider of an optimized inverter solution that has changed the way power is harvested and managed in a solar photovoltaic, known as PV systems. Our direct current or DC optimized inverter system maximizes power generation while lowering the cost of energy produced by the solar PV system, for improved return on investment, or ROI. Additional benefits of the DC optimized inverter system include comprehensive and advanced safety features, improved design flexibility, efficient integration (DC coupled) with SolarEdge storage solutions, and improved operating and maintenance, or O&M with remote monitoring at the module level. The SolarEdge Energy Hub inverter which supports, among other things, connection to a DC-coupled battery for full or partial home backup, and optional connection to the SolarEdge smart EV charger. The typical SolarEdge optimized inverter system consists of power optimizers, inverters, a communication device which enables access to a cloud-based monitoring platform and in many cases, a battery and additional smart energy management solutions. Our solutions address a broad range of solar market segments, from residential to commercial and small utility-scale solar installations.

4

Since introducing the optimized inverter solution in 2010, SolarEdge has expanded its activity to other areas of smart energy technology, both through organic growth and through acquisitions. SolarEdge now offers energy solutions which also include energy storage systems or ESS, home backup systems, electric vehicle or EV components and charging capabilities, home energy management, grid services and virtual power plants or VPPs, and lithium-ion batteries.

In the third quarter of 2020, we began commercial shipments to the U.S. from our manufacturing facility in the North of Israel, “Sella 1”. The proximity of Sella 1 to our R&D team and labs, enables us to accelerate new product development cycles, as well as define equipment and manufacturing processes of newly developed products which can then be adopted by our contract manufacturers world-wide. In 2023, we plan to expand the manufacturing capacity of Sella 1 to add an additional inverter line. In May 2022, we announced the opening of “Sella 2”, a 2GWh Li-Ion cell factory in Korea. The new factory is intended to help the Company meet the growing global demand for Li-Ion cells and batteries, specifically in the ESS market. Sella 2 began producing and shipping cells at the end of 2022 and is expected to reach full manufacturing capacity in 2023. In addition, as part of our manufacturing regionalization efforts, we expanded our manufacturing capabilities with a manufacturing site in Mexico significantly increased our capacity and gave us further flexibility to manage growing demand. In light of the Inflation Reduction Act of 2022 (“IRA”) legislation in the United States which incentivizes the local manufacturing of renewable energy products by providing benefits to installers for the purchase and installation of US-manufactured products, as well as by incentivizing manufacturers of such products domestically, we are planning to establish manufacturing capabilities in the United States by using contract manufacturers and by establishing our own manufacturing facility.

We are a leader in the global module-level power electronics or MLPE market. As of March 31, 2023, we shipped approximately 114.1 million power optimizers, 4.9 million inverters and 171.2 thousand residential batteries. Over 3.3 million installations, many of which may include multiple inverters, are currently connected to, and monitored through, our cloud-based monitoring platform. As of March 31, 2023, we shipped approximately 43.6 GW of our DC optimized inverter systems and approximately 1.2 GWh of our residential batteries.

Our revenues for the three months ended March 31, 2023, and 2022 were $943.9 million and $655.1 million, respectively. Gross margins for the three months ended March 31, 2023, and 2022 was 31.8% and 27.3%, respectively. Net income for the three months ended March 31, 2023 and 2022 was $138.4 million and $33.1 million, respectively.

Global Circumstances Influencing our Business and Operations

Covid-19 Impact & Response

Due to the worldwide growing trend in availability and administration of vaccines against Covid-19, many restrictions that were placed during the pandemic were gradually lifted by governments across the globe. However, the future impact of the Covid-19 pandemic remains highly uncertain. Resurgences of Covid-19 cases and the emergence of new variants may adversely impact our results of operations. For example, in the second quarter of 2022, the mandatory government shutdowns resulting from the increase in Covid-19 cases in Shanghai, that were eased in the beginning of the third quarter of 2022, led to delays in our scheduled shipments from the Shanghai port. Our first priority continues to be to protect and support our employees while maintaining company operations and support of our customers with as few disruptions as possible. We follow the guidance issued by applicable local authorities and health officials in each region in which we do business, including in our headquarters located in Israel.

While we have not experienced any new disruptions resulting directly from Covid-19 in the first quarter of 2023, long lasting impacts of the pandemic and general global economic conditions continue to present challenges to our operations and business. In the first quarter of 2023, we continued to witness a decrease in shipment prices and transit times, both however are still not at their pre-Covid-19 levels. In fiscal 2022 as a whole and the first quarter of 2023 specifically, the industry-wide component shortages which originated from Covid-19 and amplified by the increase in demand for our products, as well as other manufacturers who are competing for the same components, continued to impact our ability to accurately plan and forecast the delivery of our products to customers and have also increased cost of ocean and air freight for components and finished goods. To mitigate the impact of these disruptions on our supply chain, we extended in some cases shipment terms that differ from our standard terms in certain transactions, including Free-Carrier and Ex-works (INCOTERMS, 2020) delivery from our manufacturing facilities. This change was implemented as part of our ongoing efforts to expedite shipments to our customers and improve visibility throughout our supply chain. Moreover, industry-wide component shortages require our R&D teams to focus their attention on manufacturing and production design workarounds solutions, which can impact our ability to meet our plans to roll out new innovative products and services and may also result in a higher failure rate of products due to the rapid changes in product designs made prior to the commercial release of the products. Our operation team is working tirelessly to mitigate the impact of the disruptions described above.

5

Impact of Ukraine’s Conflict on the Energy Landscape

The conflict between Ukraine and Russia, which started in early 2022, and the sanctions and other measures imposed in response to this conflict have increased the level of economic and political uncertainty. While we do not have any meaningful business in Russia or Ukraine and we do not have physical assets in these countries, this conflict has, and is likely to continue to have, a multidimensional impact on the global economy, the energy landscape in general and the global supply chain. On one hand, in 2022, rising global interest in becoming less dependent on gas and oil led to higher demand for our products. On the other hand, the conflict further adversely affected the prices of raw materials arriving from Eastern Asia and resulted in an increase in gas and oil prices. Furthermore, various shipment routes were adversely impacted by the conflict resulting in increased shipment lead times and shipping costs for our products. While the impact of this conflict cannot be predicted at this time, the circumstances described above may have an adverse effect on our business and results of operations.

Inflation Reduction Act

In August 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the “IRA”), which includes several incentives intended to promote clean energy, battery and energy storage, electrical vehicles, and other solar products and is expected to impact our business and operations. As part of such incentives the IRA, will among other things, extend the investment tax credit (“ITC”) for residential solar installations through 2034 and for commercial installations through 2024 and is therefore expected to increase the demand for solar products. The IRA is expected to further incentivize residential and commercial solar customers and developers due to the inclusion of a tax credit for qualifying energy projects of up to 30%. Since these regulations are new and are still pending administrative guidance from the Internal Revenue Service and U.S. Treasury Department we will be examining the benefits that may be available to us, such as the availability of tax credits for domestic manufacturers, in the coming months. To the extent that tax benefits or credits may be available to competing technology and not to our technology, our business could be adversely disadvantaged.

6

Key Operating Metrics

In managing our business and assessing financial performance, we supplement the information provided by the financial statements with other operating metrics. These operating metrics are utilized by our management to evaluate our business, measure our performance, identify trends affecting our business and formulate projections. We use metrics relating to shipments of inverters, power optimizers and megawatts to evaluate our sales performance and to track market acceptance of our products. We use metrics relating to monitoring (systems monitored) to evaluate market acceptance of our products and usage of our solution.

We provide the “megawatts shipped” and “megawatts hour shipped” metrics, which are calculated based on inverter or battery nameplate capacity shipped, respectively, to show adoption of our system on a nameplate capacity basis. Nameplate capacity shipped is the maximum rated power output capacity of an inverter or battery, and corresponds to our financial results in that higher total nameplate capacities shipped are generally associated with higher total revenues. However, revenues may increase in a non-correlated manner to the “megawatt shipped” metric since other products such as power optimizers, are not accounted for in this metric.

	Three months ended March 31,
	2023		2022
Inverters shipped		329,653		211,114
Power optimizers shipped		6,440,683		5,724,131
Megawatts shipped1		3,608		2,130
Megawatts hour shipped - residential batteries		221		100

¹ Excluding residential batteries, based on the aggregate nameplate capacity of inverters shipped during the applicable period. Nameplate capacity is the maximum rated power output capacity of an inverter as specified by the manufacturer.

7

Results of Operations

The results of operations presented below should be reviewed in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this report.

The following table sets forth selected consolidated statements of income data for each of the periods indicated.

	Three Months Ended March 31,
	2023			2022
	(In thousands)
Revenues		943,889			655,080
Cost of revenues		643,763			476,122
Gross profit		300,126			178,958
Operating expenses:
Research and development		79,873			66,349
Sales and marketing		40,966			35,316
General and administrative		36,567			26,429
Other operating income, net		(1,434	)		—
Total operating expenses		155,972			128,094
Operating income		144,154			50,864
Financial income (expense), net		23,674			(4,605	)
Other loss		(125	)		(844	)
Income before income taxes		167,703			45,415
Income taxes		29,325			12,292
Net income		138,378			33,123

Revenues

	Three Months Ended March 31,				2022 to 2023
	2023		2022		Change
	(In thousands)
Revenues		943,889		655,080		288,809	44.1	%

Revenues increased by $288.8 million, or 44.1%, in the three months ended March 31, 2023 as compared to the three months ended March 31, 2022, primarily due to (i) an increase of $245.4 million related to the number of inverters and power optimizers sold, with significant growth in revenues coming from Europe; and (ii) an increase of $64.6 million related to the number of residential batteries, sold primarily in Europe. Revenues from outside of the U.S. comprised 72.6% of our revenues in the three months ended March 31, 2023 as compared to 59.4% in the three months ended March 31, 2022.

The number of power optimizers recognized as revenues increased by approximately 0.8 million units, or 14.7%, from approximately 5.7 million units in the three months ended March 31, 2022 to approximately 6.5 million units in the three months ended March 31, 2023. The number of inverters recognized as revenues increased by approximately 126 thousand units, or 61.2%, from approximately 206 thousand units in the three months ended March 31, 2022 to approximately 332 thousand units in the three months ended March 31, 2023.

Our blended Average Selling Price (“ASP”) per watt for solar products excluding residential batteries is calculated by dividing the solar revenues, excluding revenues from the sale of residential batteries, by the nameplate capacity of inverters shipped. Our blended ASP per watt for solar products decreased by $0.052, or 19.4%, in the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The decrease in blended ASP per watt is mainly attributed to the increase in the sale of commercial products that are characterized with lower ASP per watt, out of our total solar product mix, a relatively lower number of power optimizers and other solar products shipped compared to the number of inverters shipped, leading to a reduced overall effect on our ASP per watt. Moreover, the depreciation of the Euro and other currencies against the U.S. Dollar, coupled with our increased sales in Europe, accelerated this effect. This decrease in blended ASP per watt was partially offset by price increases that went into effect gradually during 2022 and 2023.

Our blended ASP per watt/hour for residential batteries is calculated by dividing residential batteries revenues, by the nameplate capacity of residential batteries shipped. Our blended ASP per watt/hour for residential batteries decreased by $0.055, or 10.4%, in the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The decrease in blended ASP per watt/hour is mainly attributed to the addition of a three phase battery, that is sold at a lower ASP per watt/hour, to our product portfolio and the Euro’s depreciation against the U.S. Dollar. The combination of these factors, along with our growing European battery sales, has amplified this impact.

8

Cost of Revenues and Gross Profit

	Three Months Ended March 31,				2022 to 2023
	2023		2022		Change
	(In thousands)
Cost of revenues		643,763		476,122		167,641	35.2	%
Gross profit		300,126		178,958		121,168	67.7	%

Cost of revenues increased by $167.6 million, or 35.2%, in the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, primarily due to:

• an increase in direct cost of revenues sold of $98.4 million associated primarily with an increase in the volume of products sold;

• an increase in warranty expenses and warranty accruals of $43.5 million associated primarily with an increased number of products in our install base;

• an increase of $10.0 million in inventory accrual which is mainly attributed to changes in inventory valuations, and higher inventory accruals related to our initial manufacturing in Sella 2;

• an increase in shipment and logistic costs in an aggregate amount of $5.5 million due to an increase in volumes shipped, which was partially offset by a decrease in air and expedited shipments and by a decrease in shipment rates;

• an increase in personnel-related costs of $4.8 million, related to the expansion of our production, operations, and support headcount, which grew in parallel to our growing install base worldwide and manufacturing volumes which were partially offset by the depreciation of the New Israeli Shekel (“NIS”) and the Euro against the U.S. dollar; and

• an increase in other production costs of $1.4 million, which is mainly attributed to ramp up costs associated with Sella 2.

Gross profit as a percentage of revenue increased from 27.3% in the three months ended March 31, 2022 to 31.8% in the three months ended March 31, 2023 primarily due to:

• gradual price increases across our product offerings;

• a decline in the portion of air and expedited shipments, as well as a decrease in shipment rates;

• favorable exchange rates on our cost of revenues;

• decreased custom duties in the U.S. mainly attributed to a decrease in the portion of products manufactured in China; and

• continued cost reduction efforts.

These were partially offset by:

• an increased portion of sales of commercial products out of our total product mix, that are characterized with lower gross margin ;

• unfavorable exchange rates on our sales outside of the U.S.;  

• an increase in warranty expenses and warranty accruals associated primarily with the change in the composition of our install base, as well as an increase in costs related to the different components of our warranty expenses, as reflected in our actual support costs; and

• a negative impact on margin attributed to our non-solar businesses, that are characterized by a lower gross profit.

9

Operating Expenses:

Research and Development

	Three months ended March 31,				2022 to 2023
	2023		2022		Change
	(In thousands)
Research and development		79,873		66,349		13,524	20.4	%

Research and development costs increased by $13.5 million or 20.4%, in the three months ended March 31, 2023 compared to the three months ended March 31, 2022, primarily due to:

• an increase in personnel-related costs of $8.5 million resulting from an increase in our research and development headcount, as well as salary expenses associated with employee equity-based compensation. The increase in headcount reflects our continuing investment in enhancements of existing products, as well as research and development expenses associated with bringing new products to the market, which were partially offset by the depreciation of the NIS and the Euro against the U.S. dollar;

• an increase in expenses related to consultants and sub-contractors in an amount of $2.8 million; and

• an increase in expenses related to overhead costs in an amount of $1.7 million.

Sales and Marketing

	Three months ended March 31,				2022 to 2023
	2023		2022		Change
	(In thousands)
Sales and marketing		40,966		35,316		5,650	16.0	%

Sales and marketing expenses increased by $5.7 million, or 16.0%, in the three months ended March 31, 2023 compared to the three months ended March 31, 2022, primarily due to:

• an increase in personnel-related costs of $3.8 million as a result of an increase in headcount supporting our growth in all geographies, as well as salary expenses associated with employee equity-based compensation, partially offset by the depreciation of the NIS and the Euro against the U.S. dollar; and

• an increase of $1.4 million in training-related expenses as a result of resuming training activities that had been previously cancelled or postponed due to Covid-19 restrictions in prior years.

10

General and Administrative

	Three months ended March 31,				2022 to 2023
	2023		2022		Change
	(In thousands)
General and administrative		36,567		26,429		10,138	38.4	%

General and administrative expenses increased by $10.1 million, or 38.4%, in the three months ended March 31, 2023 compared to the three months ended March 31, 2022, primarily due to:

• an increase in expenses related to consultants and sub-contractors in an amount of $5.0 million;

• an increase in personnel-related costs of $2.9 million resulting from an increase in our general and administrative headcount, as well as salary expenses associated with employee equity-based compensation, partially offset by the depreciation of the NIS and the Euro against the U.S. dollar; and

• an increase in expenses related to an accrual for doubtful debts in an amount of $0.9 million.

Other operating income

	Three months ended March 31,					2022 to 2023
	2023			2022		Change
	(In thousands)
Other operating income, net		(1,434	)		—		(1,434	)	(100.0	)%

Other operating income, net increased by $1.4 million, in the three months ended March 31, 2023 compared to the three months ended March 31, 2022 due to an increase in income related to the sale of property, plant and equipment and other assets.

 
Financial income (expense), net

	Three months ended March 31,					2022 to 2023
	2023		2022			Change
	(In thousands)
Financial income (expense), net		23,674		(4,605	)		28,279	(614.1	)%

Financial income, net, was $23.7 million in the three months ended March 31, 2023, compared to financial expenses, net, in the amount of $4.6 million in the three months ended March 31, 2022, primarily due to:

• an increase of $25.4 million in income due to fluctuations in foreign exchange rates, primarily between the Euro and the NIS against the U.S. dollar; and

• an increase of $2.7 million related to interest income from marketable securities.

11

Other loss

	Three months ended March 31,						2022 to 2023
	2023			2022			Change
	(In thousands)
Other loss		(125	)		(844	)		719	(85.2	)%

Other loss decreased by $0.7 million, or 85.2%, in the three months ended March 31, 2023, compared to the three months ended March 31, 2022, due to a decrease in realized loss on marketable securities.

Income taxes

	Three months ended March 31,				2022 to 2023
	2023		2022		Change
	(In thousands)
Income taxes		29,325		12,292		17,033	138.6	%

Income taxes increased by $17.0 million, or 138.6%, in the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, primarily due to an increase of $19.6 million in current tax expenses, mainly attributed to an increase in profit before tax in our foreign subsidiaries. This increase was partially offset by an increase of $2.7 million in deferred tax income.

Net Income

	Three months ended March 31,				2022 to 2023
	2023		2022		Change
	(In thousands)
Net income		138,378		33,123		105,255	317.8	%

 

As a result of the factors discussed above, net income increased by $105.3 million, or 317.8% in the three months ended March 31, 2023 as compared to the three months ended March 31, 2022.

Liquidity and Capital Resources

The following table shows our cash flows from operating activities, investing activities, and financing activities for the stated periods:

	Three Months Ended March 31,
	2023			2022
	(In thousands)
Net cash provided by (used in) operating activities		7,923			(162,989	)
Net cash used in investing activities		(67,780	)		(15,134	)
Net cash provided by (used in) financing activities		(5,222	)		652,335
Increase (decrease) in cash and cash equivalents		(65,079	)		474,212

12

As of March 31, 2023, our cash and cash equivalents were $727.8 million. This amount does not include $919.9 million invested in available-for-sale marketable securities and $0.3 million invested in restricted bank deposits. Our principal uses of cash are for funding our operations, capital expenditures, other working capital requirements and other investments. As of March 31, 2023, we have open commitments for capital expenditures in an amount of approximately $121.3 million. These commitments mainly reflect purchases of automated assembly lines and other machinery related to our manufacturing and operations. We also have purchase obligations in the amount of $1,617.4 million related to raw materials and commitments for the future manufacturing of our products.

We believe that cash provided by operating activities, as well as our cash and cash equivalents and available-for-sale marketable securities, will be sufficient to meet our anticipated cash needs for at least the next 12 months, as well as in the longer term, including the self-funding of our capital expenditure and operational commitments.

Operating Activities

Operating cash flows consists primarily of net income adjusted for certain non-cash items and changes in assets and liabilities. Cash provided by operating cash flows in the three months ended March 31, 2023 was $7.9 million as compared to $163.0 million used in operating activities in the three months ended March 31, 2022, mainly due to higher net income adjusted for certain non-cash items and favorable changes in working capital due to a decrease in shipping times to customers which shortened the period of time between payment to our vendors and delivery to and collection from our customers, partially offset by an increase in inventory procurement in response to increased demand for our products and increased purchasing of battery cells for our residential storage solution.

Investing Activities

Investing cash flows consist primarily of capital expenditures, investment in, sales and maturities of available for sale marketable securities, investment and withdrawal of bank deposits and restricted bank deposits, cash used for acquisitions and cash provided by the sale of equity investments. Cash used for investing activities increased by $52.6 million in the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, primarily driven by a $41.5 million decrease in proceeds provided by sales and maturities of available-for-sale marketable securities, an increase of $12.3 million in investments in available-for-sale marketable securities, and by a $5.5 million increase in an investment in a privately-held company. This increase in cash used for investing activities was partially offset by a decrease of $4.9 million in capital expenditures, as well as a $1.4 million increase in cash provided due to withdrawal from bank deposits and restricted bank deposits.

Financing Activities

Financing cash flows consisted primarily of the issuance and repayment of short-term and long-term debt and proceeds from the sale of shares of common stock in a public offering and employee equity incentive plans. Cash used in financing activities in the three months ended March 31, 2023 was $5.2 million compared to $652.3 million cash provided by financing activities in the three months ended March 31, 2022, primarily due to a $650.5 million decrease in cash provided by the issuance of common stock, net through a secondary public offering which occurred in March 2022.

Secondary public offering

On March 17, 2022, we offered and sold 2,300,000 shares of the Company’s common stock at a public offering price of $295.00 per share. The net proceeds to the Company after underwriters’ discounts and commissions and offering costs were $650.5 million. We intend to use the proceeds from the public offering for general corporate purposes, which may include acquisitions. See Note 11b to our condensed consolidated financial statements for more information.

13

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates, customer concentrations and interest rates. We do not hold or issue financial instruments for trading purposes.

Foreign Currency Exchange Risk

Approximately 69.5% and 56.9% of our revenues for the three months ended March 31, 2023, and 2022, respectively, were earned in non U.S. dollar denominated currencies, principally the Euro. Our expenses are generally denominated in the currencies in which our operations are located, primarily the U.S. dollar, New Israeli Shekel (“NIS”), Euro, and to a lesser extent, the South Korean Won (“KRW”). Our NIS denominated expenses consist primarily of personnel and overhead costs. Our consolidated results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates and may be adversely affected in the future due to changes in foreign exchange rates. A hypothetical 10% change in foreign currency exchange rates between the Euro and the U.S. dollar would increase or decrease our net income by $95.3 million for the three months ended March 31, 2023. A hypothetical 10% change in foreign currency exchange rates between the NIS and the U.S. dollar would increase or decrease our net income by $9.1 million for the three months ended March 31, 2023.

For purposes of our consolidated financial statements, local currency assets and liabilities are translated at the rate of exchange to the U.S. dollar on the balance sheet date, and local currency revenues and expenses are translated at the exchange rate as of the date of the transaction or at the average exchange rate to the U.S. dollar during the reporting period.

To date, we have used derivative financial instruments, specifically foreign currency forward contracts and put and call options, to manage exposure to foreign currency risks by hedging portions of the anticipated payroll payments denominated in NIS. These derivative instruments are designated as cash flow hedges.

In addition, from time to time we enter into derivative financial instruments to hedge the Company’s exposure to currencies other than the U.S. dollar, mainly forward contracts to sell Euro and AUD for U.S. dollars. These derivative instruments are not designated as cash flow hedges.

Concentrations of Major Customers

Our trade accounts receivables potentially expose us to a concentration of credit risk with our major customers. As of March 31, 2023, two major customers jointly accounted for approximately 27.8% of our consolidated trade receivables, net balance. As of December 31, 2022, three major customers jointly accounted for approximately 42.4% of our consolidated trade receivables, net balance. For the three months ended March 31, 2023 two major customers jointly accounted for approximately 21.9% of our total revenues. For the three months ended March 31, 2022 one major customer accounted for approximately 23.5% of our total revenues.

Commodity Price Risk

We are subject to risk from fluctuating market prices of certain commodity raw materials which are used in our products, including Copper, Lithium, Nickel and Cobalt. Prices of these raw materials may be affected by supply restrictions or other market factors from time to time, and we do not enter into hedging arrangements to mitigate commodity risk. Significant price changes for these raw materials could reduce our operating margins if we are unable to recover such increases from our customers, and could harm our business, financial condition, and results of operations.

14

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of March 31, 2023. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective and operating to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and to provide reasonable assurance that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the third fiscal quarter of 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

15

PART II. OTHER INFORMATION.

ITEM 1. Legal Proceedings

In the normal course of business, we may from time to time be named as a party to various legal claims, actions and complaints (including as a result of initiating such legal claims, action or complaints on behalf of the Company), including the matters described in Item 3 – “Legal Proceedings” of our Annual Report on Form 10-K for the period ended December 31, 2022 and subsequent quarterly filings. It is impossible to predict with certainty whether any resulting liability from any such legal claims, actions or complaints would have a material adverse effect on our financial position, results of operations or cash flows.

ITEM 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the risk factors as described in Part I, Item 1A, “Risk Factors”, in our Annual Report on Form 10-K for the year ended December 31, 2022.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None

ITEM 3. Defaults upon Senior Securities.

None

ITEM 4. Mine Safety Disclosures

Not applicable.

ITEM 5. Other Information

None

16

ITEM 6. Exhibits

Index to Exhibits

Exhibit No.	Description	Incorporation by Reference
31.1	Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and15d-14(a) of the Securities Exchange Act of 1934, as amended	Filed with this report.
31.2	Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and15d-14(a) of the Securities Exchange Act of 1934, as amended	Filed with this report.
32.1	Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Filed with this report.
32.2	Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Filed with this report.
101	The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements	Filed with this report.
104	The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 formatted in Inline XBRL	Included in Exhibit 101

17

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: May 8, 2023
	/s/Zvi Lando
	Zvi Lando
	Chief Executive Officer
	(Principal Executive Officer)
Date: May 8, 2023
	/s/ Ronen Faier
	Ronen Faier
	Chief Financial Officer
	(Principal Financial Officer)

18

EX-31.1

Exhibit 31.1

I, Zvi Lando, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of SolarEdge Technologies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 8, 2023

/s/ Zvi Lando

Zvi Lando

Chief Executive Officer

(Principal Executive Officer)

EX-31.2

Exhibit 31.2

I, Ronen Faier, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of SolarEdge Technologies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 8, 2023

/s/ Ronen Faier

Ronen Faier

Chief Financial Officer

(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Zvi Lando, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of SolarEdge Technologies, Inc. for the quarterly period ended March 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of SolarEdge Technologies, Inc.

Date:  May 8, 2023

/s/ Zvi Lando

Zvi Lando

Chief Executive Officer

(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Ronen Faier, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of SolarEdge Technologies, Inc. for the quarterly period ended March 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of SolarEdge Technologies, Inc.

Date:  May 8, 2023

/s/ Ronen Faier

Ronen Faier

Chief Financial Officer

(Principal Financial Officer)

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2023	May 01, 2023
Cover [Abstract]
Entity Registrant Name	SOLAREDGE TECHNOLOGIES, INC.
Entity Central Index Key	0001419612
Document Type	10-Q
Document Period End Date	Mar. 31, 2023
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-36894
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-5338862
Entity Address, Country	IL
Entity Address, City or Town	Herziliya Pituach
Entity Address, Address Line One	1 HaMada Street
Entity Address, Postal Zip Code	4673335
City Area Code	972
Local Phone Number	(9) 957-6620
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Title of each class	Common stock, par value $0.0001 per share
Trading Symbol	SEDG
Name of Exchange on which Security is Registered	NASDAQ
Entity Common Stock, Shares Outstanding		56,344,727

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 727,849	$ 783,112
Marketable securities	410,820	241,117
Trade receivables, net of allowances of $4,422 and $3,202, respectively	969,543	905,146
Inventories, net	874,212	729,201
Prepaid expenses and other current assets	259,642	241,082
Total current assets	3,242,066	2,899,658
LONG-TERM ASSETS:
Marketable securities	509,127	645,491
Deferred tax assets, net	46,612	44,153
Property, plant and equipment, net	556,138	543,969
Operating lease right-of-use assets, net	69,710	62,754
Intangible assets, net	17,933	19,929
Goodwill	29,934	31,189
Other long-term assets	24,906	18,806
Total long-term assets	1,254,360	1,366,291
Total assets	4,496,426	4,265,949
CURRENT LIABILITIES:
Trade payables, net	408,523	459,831
Employees and payroll accruals	90,853	85,158
Warranty obligations	129,278	103,975
Deferred revenues and customers advances	27,507	26,641
Accrued expenses and other current liabilities	243,881	214,112
Total current liabilities	900,042	889,717
LONG-TERM LIABILITIES:
Convertible senior notes, net	625,182	624,451
Warranty obligations	313,693	281,082
Deferred revenues	196,917	186,936
Finance lease liabilities	43,711	45,385
Operating lease liabilities	50,855	46,256
Other long-term liabilities	15,232	15,756
Total long-term liabilities	1,245,590	1,199,866
COMMITMENTS AND CONTINGENT LIABILITIES
STOCKHOLDERS' EQUITY:
Common stock of $0.0001 par value - Authorized: 125,000,000 shares as of March 31, 2023 and December 31, 2022; issued and outstanding: 56,343,164 and 56,133,404 shares as of March 31, 2023 and December 31, 2022, respectively	6	6
Additional paid-in capital	1,545,777	1,505,632
Accumulated other comprehensive loss	(77,204)	(73,109)
Retained earnings	882,215	743,837
Total stockholders’ equity	2,350,794	2,176,366
Total liabilities and stockholders’ equity	$ 4,496,426	$ 4,265,949

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Allowances of trade receivable	$ 4,422	$ 3,202
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, authorized shares	125,000,000	125,000,000
Common stock, issued shares	56,343,164	56,133,404
Common stock, outstanding shares	56,343,164	56,133,404

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenues	$ 943,889	$ 655,080
Cost of revenues	643,763	476,122
Gross profit	300,126	178,958
Operating expenses:
Research and development	79,873	66,349
Sales and marketing	40,966	35,316
General and administrative	36,567	26,429
Other operating income, net	(1,434)	0
Total operating expenses	155,972	128,094
Operating income	144,154	50,864
Financial income (expense), net	23,674	(4,605)
Other loss	(125)	(844)
Income before income taxes	167,703	45,415
Income taxes	29,325	12,292
Net income	$ 138,378	$ 33,123
Net income per share:
Net basic earnings per share of common stock	$ 2.46	$ 0.62
Net diluted earnings per share of common stock	$ 2.35	$ 0.6
Weighted average number of shares used in computing net basic earnings per share of common stock	56,215,490	53,134,937
Weighted average number of shares used in computing net diluted earnings per share of common stock	59,193,831	56,315,193

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 138,378	$ 33,123
Other comprehensive income (loss), net of tax:
Available-for-sale marketable securities	6,177	(9,506)
Cash flow hedges	(331)	(680)
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment nature	(10,800)	(6,983)
Foreign currency translation adjustments	859	(1,579)
Total other comprehensive loss	(4,095)	(18,748)
Comprehensive income	$ 134,283	$ 14,375

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]		Additional paid in capital [Member]	Accumulated Other comprehensive income (loss) [Member]	Retained earnings [Member]	Total
Balance at Dec. 31, 2021	$ 5		$ 687,295	$ (27,319)	$ 650,058	$ 1,310,039
Balance (in shares) at Dec. 31, 2021	52,815,395
Issuance of common stock upon exercise of stock-based awards	$ 0	[1]	1,478	0	0	1,478
Issuance of common stock upon exercise of stock-based awards (in shares)	270,751
Stock based compensation	$ 0		34,107	0	0	34,107
Issuance of common stock in a secondary public offering, net of underwriters' discounts and commissions of $27,140 and $834 of offering costs	$ 1		650,525	0	0	650,526
Issuance of common stock in a secondary public offering, net of underwriters' discounts and commissions of $27,140 and $834 of offering costs (in shares)	2,300,000
Other comprehensive loss adjustments	$ 0		0	(18,748)	0	(18,748)
Net income	0		0	0	33,123	33,123
Balance at Mar. 31, 2022	$ 6		1,373,405	(46,067)	683,181	2,010,525
Balance (in shares) at Mar. 31, 2022	55,386,146
Balance at Dec. 31, 2022	$ 6		1,505,632	(73,109)	743,837	2,176,366
Balance (in shares) at Dec. 31, 2022	56,133,404
Issuance of common stock upon exercise of stock-based awards	$ 0	[1]	75	0	0	75
Issuance of common stock upon exercise of stock-based awards (in shares)	209,760
Stock based compensation	$ 0		40,070	0	0	40,070
Other comprehensive loss adjustments	0		0	(4,095)	0	(4,095)
Net income	0		0	0	138,378	138,378
Balance at Mar. 31, 2023	$ 6		$ 1,545,777	$ (77,204)	$ 882,215	$ 2,350,794
Balance (in shares) at Mar. 31, 2023	56,343,164

[1] Represents an amount less than $1.

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) $ in Thousands	3 Months Ended
	Mar. 31, 2022 USD ($)
Statement of Stockholders' Equity [Abstract]
Underwriters discounts and commissions	$ 27,140
Offering costs	$ 834

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income	$ 138,378	$ 33,123
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	13,464	11,660
Stock-based compensation expenses	39,235	34,107
Deferred income taxes, net	(3,930)	(1,034)
Loss (gain) from exchange rate fluctuations	(20,441)	1,725
Other items	2,810	4,167
Changes in assets and liabilities:
Inventories, net	(141,521)	(51,323)
Prepaid expenses and other assets	(20,591)	(17,163)
Trade receivables, net	(55,002)	(224,865)
Trade payables, net	(50,410)	(28,045)
Employees and payroll accruals	10,227	9,246
Warranty obligations	57,864	27,629
Deferred revenues and customers advances	9,325	15,029
Accrued expenses and other liabilities, net	28,515	22,755
Net cash provided by (used in) operating activities	7,923	(162,989)
Cash flows from investing activities:
Proceed from sales and maturities of available-for-sale marketable securities	11,597	53,096
Purchase of property, plant and equipment	(38,338)	(43,210)
Investment in available-for-sale marketable securities	(38,979)	(26,712)
Investment in a privately-held company	(5,500)	0
Other investing activities	3,440	1,692
Net cash used in investing activities	(67,780)	(15,134)
Cash flows from financing activities:
Proceeds from secondary public offering, net of issuance costs	0	650,526
Proceeds from exercise of stock-based awards	75	1,478
Tax withholding in connection with stock-based awards, net	(4,541)	822
Other financing activities	(756)	(491)
Net cash provided by (used in) financing activities	(5,222)	652,335
Increase (decrease) in cash and cash equivalents	(65,079)	474,212
Cash and cash equivalents at the beginning of the period	783,112	530,089
Effect of exchange rate differences on cash and cash equivalents	9,816	(1,529)
Cash and cash equivalents at the end of the period	727,849	1,002,772
Supplemental disclosure of non-cash activities:
Right-of-use asset recognized with a corresponding lease liability	11,258	27,248
Purchase of property, plant and equipment	$ 12,304	$ 19,536

XML

GENERAL

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GENERAL

NOTE 1:      GENERAL

a. SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughput from each and every module through constant tracking of Maximum Power Point individually per module, (ii) inverters which invert direct current (DC) from the PV module to alternating current (AC) including the Company’s Energy Hub inverter which supports, among other things, connection to a DC-coupled battery for full or partial home backup, and optional connection to the Company's smart EV charger, (iii) a remote cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters to enable customers and system owners, to monitor and manage the solar PV system (iv) a residential storage and backup solution which includes a company designed and manufactured lithium-ion DC-coupled battery that is used to increase energy independence and maximize self-consumption for homeowners including a battery, and (v) additional smart energy management solutions.

The Company and its subsidiaries sell products worldwide through large distributors, electrical equipment wholesalers, as well as directly to large solar installers and engineering, procurement, and construction firms.

b. The Company has expanded its activity to other areas of smart energy technology organically and through acquisitions. The Company now offers a variety of energy solutions, which include lithium-ion cells, batteries, and energy storage systems (“Energy Storage”), full powertrain kits for electric vehicles, or EVs (“e-Mobility”), as well as automated machines for industrial use (“Automation Machines”).

c. Basis of Presentation:

The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. The Company’s interim period results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year.

The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2022, contained in the Company’s Annual Report on Form 10-K filed with the SEC on February 22, 2023, have been applied consistently in these unaudited interim condensed consolidated financial statements. Certain prior year amounts have been reclassified to conform to current year presentation.

d. Use of estimates:

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes. The duration, scope and effects of the ongoing Covid-19 pandemic and the conflict in Ukraine, government and other third-party responses to it, and the related macroeconomic effects, including to the Company’s business and the business of the Company’s suppliers and customers are uncertain, rapidly changing and difficult to predict. As a result, the Company’s accounting estimates and assumptions may change over time in response to this evolving situation. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, inventories, incremental credit losses on receivables and available-for-sale marketable debt securities, or an increase in the Company’s insurance liabilities as of the time of a relevant measurement event.

e. Concentrations of supply risks:

The Company depends on two contract manufacturers and several limited or single source component suppliers. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields, and costs.

As of March 31, 2023, and December 31, 2022, two contract manufacturers collectively accounted for 31.3% and 34.3% of the Company’s total trade payables, net, respectively.

In the second quarter of 2022, the Company announced the opening of “Sella 2”, a two gigawatt-hour (GWh) Li-Ion battery cell manufacturing facility located in South Korea. Sella 2 began producing and shipping cells at the end of 2022 and is expected to reach full manufacturing capacity in 2023. Sella 2 is the Company's second owned manufacturing facility following the establishment of Sella 1 in 2020. Sella 1 is the Company's manufacturing facility in the North of Israel that produces power optimizers and inverters for the Company's solar activities.

f. New accounting standards updates:

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") or other standard setting bodies are adopted by the Company as of the specified effective date. The Company believes that the impact of recently issued or newly effective standards were not applicable to the Company, did not have a material impact on the condensed consolidated financial statements or are not expected to have a material impact on the condensed consolidated financial statements.

XML

MARKETABLE SECURITIES

3 Months Ended

Mar. 31, 2023

Marketable Securities [Abstract]

MARKETABLE SECURITIES

NOTE 2:       MARKETABLE SECURITIES

The following is a summary of available-for-sale marketable securities as of March 31, 2023:

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale – matures within one year:
Corporate bonds	$	390,012	$	82	$	(8,595	)	$	381,499
Governmental bonds		29,788		-		(467	)		29,321
		419,800		82		(9,062	)		410,820
Available-for-sale – matures after one year:
Corporate bonds		515,425		698		(15,855	)		500,268
Governmental bonds		9,251		-		(392	)		8,859
		524,676		698		(16,247	)		509,127
Total	$	944,476	$	780	$	(25,309	)	$	919,947

The following is a summary of available-for-sale marketable securities as of December 31, 2022:

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale – matures within one year:
Corporate bonds	$	222,482	$	-	$	(4,657	)	$	217,825
Governmental bonds		23,845		-		(553	)		23,292
		246,327		-		(5,210	)		241,117
Available-for-sale – matures after one year:
Corporate bonds		657,238		80		(26,460	)		630,858
Governmental bonds		15,250		-		(617	)		14,633
		672,488		80		(27,077	)		645,491
Total	$	918,815	$	80	$	(32,287	)	$	886,608

As of March 31, 2023, and December 31, 2022, the Company did not record an allowance for credit losses for its available-for-sale marketable securities.

XML

INVENTORIES, NET

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

INVENTORIES, NET

NOTE 3:       INVENTORIES, NET

	March 31, 2023		December 31, 2022
Raw materials	$	503,445	$	503,257
Work in process		37,754		23,407
Finished goods		333,013		202,537
Total inventories, net	$	874,212	$	729,201

XML

PREPAID EXPENSES AND OTHER CURRENT ASSETS

3 Months Ended

Mar. 31, 2023

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

PREPAID EXPENSES AND OTHER CURRENT ASSETS

NOTE 4:       PREPAID EXPENSES AND OTHER CURRENT ASSETS

	March 31, 2023		December 31, 2022
Vendor non-trade receivables (*)	$	147,238	$	147,597
Government authorities		57,275		55,670
Prepaid expenses and other		55,129		37,815
Total prepaid expenses and other current assets	$	259,642	$	241,082

(*) Vendor non-trade receivables derived from the sale of components to manufacturing vendors who manufacture products for the Company. The Company purchases these components directly from other suppliers. The Company does not reflect the sale of these components to the contract manufacturers in its revenues.

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

3 Months Ended

Mar. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

NOTE 5:       DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

During the three months ended March 31, 2023, the Company instituted a foreign currency cash flow hedging program to reduce the risk of a forecasted increase in the value of foreign currency cash flows, resulting from payment of salaries in Israeli currency, the New Israeli Shekels (“NIS”). The Company hedges portions of the anticipated payroll denominated in NIS for a period of one to nine months with hedging contracts. These hedging contracts are designated as cash flow hedges, as defined by ASC 815 and are all effective hedges.

As of March 31, 2023, the Company entered into forward contracts and put and call options to sell U.S. dollars (“USD”) for NIS in the amount of approximately NIS 231 million and NIS 125 million, respectively.

In addition to the above-mentioned cash flow hedge transactions, the Company occasionally enters into derivative instrument arrangements to hedge the Company’s exposure to currencies other than the USD. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the statement of income, under "Financial income (expense), net".

The Company classifies cash flows related to its hedging as operating activities in its condensed consolidated statement of cash flows.

The fair values of outstanding derivative instruments were as follows:

	Balance sheet location	March 31, 2023			December 31, 2022
Derivative assets of options and forward contracts:
Designated cash flow hedges	Prepaid expenses and other current assets	$	353		$	-
Derivative liabilities of options and forward contracts:
Designated cash flow hedges	Accrued expenses and other current liabilities	$	(2,583	)	$	(1,874	)

Gains (losses) on derivative instruments are summarized below:

		Three Months Ended March 31,
	Affected line item	2023			2022
Foreign exchange contracts
Non Designated Hedging Instruments	Condensed Consolidated Statements of Income - Financial income (expense), net	$	-		$	934
Designated Hedging Instruments	Condensed Consolidated Statements of Comprehensive Income - Cash flow hedges	$	(2,057	)	$	(1,178	)

See Note 13 for information regarding losses from designated hedging instruments reclassified from accumulated other comprehensive loss.

XML

FAIR VALUE MEASUREMENTS

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

NOTE 6:    FAIR VALUE MEASUREMENTS

In accordance with ASC 820, the Company measures its cash equivalents and marketable securities, at fair value using the market approach valuation technique. Cash and cash equivalents are classified within Level 1 because these assets are valued using quoted market prices. Marketable securities and foreign currency derivative contracts are classified within level 2 due to these assets being valued by alternative pricing sources and models utilizing market observable inputs.

The following table sets forth the Company’s assets that were measured at fair value as of March 31, 2023 and December 31, 2022, by level within the fair value hierarchy:

	Fair Value Hierarchy	Fair value measurements as of
Description		March 31, 2023			December 31, 2022
Assets:
Cash and cash equivalents:
Cash	Level 1	$	667,384		$	695,004
Money market mutual funds	Level 1	$	17,486		$	25,149
Deposits	Level 1	$	42,979		$	62,959
Derivative instruments	Level 2	$	353		$	-
Short-term marketable securities:
Corporate bonds	Level 2	$	381,499		$	217,825
Governmental bonds	Level 2	$	29,321		$	23,292
Long-term marketable securities:
Corporate bonds	Level 2	$	500,268		$	630,858
Governmental bonds	Level 2	$	8,859		$	14,633
Liabilities:
Derivative instruments	Level 2	$	(2,583	)	$	(1,874	)

XML

WARRANTY OBLIGATIONS

3 Months Ended

Mar. 31, 2023

Product Warranties Disclosures [Abstract]

WARRANTY OBLIGATIONS

NOTE 7:       WARRANTY OBLIGATIONS

Changes in the Company’s product warranty obligations for the three months ended March 31, 2023 and 2022, were as follows:

	Three Months Ended March 31,
	2023			2022
Balance, at the beginning of the period	$	385,057		$	265,160
Additions and adjustments to cost of revenues		91,570			47,907
Usage and current warranty expenses		(33,656	)		(20,401	)
Balance, at end of the period		442,971			292,666
Less current portion		(129,278	)		(82,340	)
Long term portion	$	313,693		$	210,326

XML

DEFERRED REVENUES AND CUSTOMERS ADVANCES

3 Months Ended

Mar. 31, 2023

Revenue Recognition and Deferred Revenue [Abstract]

DEFERRED REVENUES AND CUSTOMERS ADVANCES

NOTE 8:       DEFERRED REVENUES AND CUSTOMERS ADVANCES

Deferred revenues consist of deferred cloud-based monitoring services, communication services, warranty extension services and advance payments received from customers for the Company’s products. Deferred revenues are classified as short-term and long-term deferred revenues based on the period in which revenues are expected to be recognized.

Significant changes in the balances of deferred revenues and customer advances during the period are as follows:

	Three Months Ended March 31,
	2023			2022
Balance, at the beginning of the period	$	213,577		$	169,345
Revenue recognized		(11,742	)		(14,529	)
Increase in deferred revenues and customer advances		22,589			29,429
Balance, at the end of the period		224,424			184,245
Less current portion		(27,507	)		(25,511	)
Long term portion	$	196,917		$	158,734

The following table includes estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) as of March 31, 2023:

2023	$	23,888
2024		12,073
2025		10,764
2026		10,389
2027		8,363
Thereafter		158,947
Total deferred revenues	$	224,424

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

3 Months Ended

Mar. 31, 2023

Payables and Accruals [Abstract]

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

NOTE 9:       ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

	March 31, 2023		December 31, 2022
Accrued expenses	$	127,018	$	117,638
Government authorities		87,159		67,514
Operating lease liabilities		17,215		16,183
Accrual for sales incentives		5,746		6,790
Other		6,743		5,987
Total accrued expenses and other current liabilities	$	243,881	$	214,112

XML

CONVERTIBLE SENIOR NOTES

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Convertible Senior Notes

NOTE 10:       CONVERTIBLE SENIOR NOTES

On September 25, 2020, the Company sold $632,500 aggregate principal amount of its 0.00% convertible senior notes due 2025 (the “Notes”). The Notes were sold pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes do not bear regular interest and mature on September 15, 2025, unless earlier repurchased or converted in accordance with their terms. The Notes are general senior unsecured obligations of the Company. Holders may convert their Notes prior to the close of business on the business day immediately preceding June 15, 2025 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2020 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five-business-day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each trading day of that five consecutive trading day period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events as described in the Indenture. In addition, holders may convert their Notes, in multiples of $1,000 principal amount, at their option at any time beginning on or after June 15, 2025, and prior to the close of business on the second scheduled trading day immediately preceding the stated maturity date of the Notes, without regard to the foregoing circumstances. The initial conversion rate for the Notes was 3.5997 shares of common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $277.80 per share of common stock, subject to adjustment upon the occurrence of certain specified events as set forth in the Indenture.

Upon conversion, the Company may choose to pay or deliver, as the case may be, cash, shares of common stock, or a combination of cash and shares of common stock.

In addition, upon the occurrence of a fundamental change (as defined in the Indenture), holders of the Notes may require the Company to repurchase all or a portion of their Notes, in multiples of $1,000 principal amount, at a repurchase price of 100% of the principal amount of the Notes, plus any accrued and unpaid special interest to, but excluding the fundamental change repurchase date. If certain fundamental changes referred to as make-whole fundamental changes occur, the conversion rate for the Notes may be increased.

The Convertible Senior Notes consisted of the following as of March 31, 2023 and December 31, 2022:

	March 31, 2023			December 31, 2022
Liability:
Principal	$	632,500		$	632,500
Unamortized issuance costs		(7,318	)		(8,049	)
Net carrying amount	$	625,182		$	624,451

For the three months ended March 31, 2023 and 2022 the Company recorded amortized debt issuance costs related to the Notes in the amount of $731 and $728, respectively.

As of March 31, 2023, the unamortized issuance costs of the Notes will be amortized over the remaining term of approximately 2.5 years.

The annual effective interest rate of the Notes is 0.47%.

As of March 31, 2023, the estimated fair value of the Notes, which the Company has classified as Level 2 financial instruments, is $823,730. The estimated fair value was determined based on the quoted bid price of the Notes in an over-the-counter market on the last trading day of the reporting period.

As of March 31, 2023, the if-converted value of the Notes exceeded the principal amount by $59,537.

XML

STOCK CAPITAL

3 Months Ended

Mar. 31, 2023

Share-based Payment Arrangement [Abstract]

STOCK CAPITAL

NOTE 11:       STOCK CAPITAL

a. Common stock rights:

Common stock confers upon its holders the right to receive notice of, and to participate in, all general meetings of the Company, where each share of common stock shall have one vote for all purposes, to share equally, on a per share basis, in bonuses, profits, or distributions out of fund legally available therefor, and to participate in the distribution of the surplus assets of the Company in the event of liquidation of the Company.

b. Secondary public offering:

On March 17, 2022, the Company offered and sold 2,300,000 shares of the Company’s common stock, at a public offering price of $295.00 per share. The shares of Common Stock were issued and sold in a registered offering pursuant to the underwriting agreement dated March 17, 2022, among the Company, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Morgan Stanley & Co. LLC (the “Underwriting Agreement”). All of the offered shares were issued at closing, including 300,000 shares of Common Stock that were issued and sold pursuant to the underwriters’ option to purchase additional shares under the Underwriting Agreement, which was exercised in full on March 18, 2022.

The net proceeds to the Company were $650,526 after deducting underwriters' discounts of $27,140 and commissions of $834.

c. Equity Incentive Plans:

The Company’s 2007 Global Incentive Plan (the “2007 Plan”) was adopted by the board of directors on August 30, 2007. The 2007 Plan terminated upon the Company’s IPO on March 31, 2015 and no further awards may be granted thereunder. All outstanding awards will continue to be governed by their existing terms and 379,358 available options for future grants were transferred to the Company’s 2015 Global Incentive Plan (the “2015 Plan”) and are reserved for future issuances under the 2015 plan. The 2015 Plan became effective upon the consummation of the IPO. The 2015 Plan provides for the grant of options, restricted stock units ("RSU"), performance stock units ("PSU"), and other share-based awards to directors, employees, officers, and non-employees of the Company and its subsidiaries. As of March 31, 2023, a total of 20,853,755 shares of common stock were reserved for issuance pursuant to stock awards under the 2015 Plan (the “Share Reserve”), an aggregate of 12,005,195 shares are still available for future grants.

The Share Reserve will automatically increase on January 1^st of each year during the term of the 2015 Plan, commencing on January 1^st  of the year following the year in which the 2015 Plan becomes effective, in an amount equal to 5% of the total number of shares of capital stock outstanding on December 31^st of the preceding calendar year; provided, however, that the Company’s board of directors may determine that there will not be a January 1^st increase in the Share Reserve in a given year or that the increase will be less than 5% of the shares of capital stock outstanding on the preceding December 31^st.

The Company granted under its 2015 Plan, PSU awards to certain employees and officers which vest upon the achievement of certain performance or market conditions subject to their continued employment with the Company.

In 2021, the Company has also committed to issuing additional shares, which carry certain performance conditions (including business performance targets and a continued service relationship with the Company) and are treated as PSUs for accounting purposes.
 

The market condition for the PSUs is based on the Company’s total shareholder return ("TSR") compared to the TSR of companies listed in the S&P 500 index over a one to three year performance period. The Company uses a Monte-Carlo simulation to determine the grant date fair value for these awards, which takes into consideration the market price of a share of the Company’s common stock on the date of grant less the present value of dividends expected during the requisite service period, as well as the possible outcomes pertaining to the TSR market condition. The Company recognizes such compensation expenses on an accelerated vesting method.

The aggregate maximum number of shares of common stock that may be issued on the exercise of incentive stock options is 10,000,000. As of March 31, 2023, an aggregate of 8,617,974 options are still available for future grants under the 2015 Plan.

A summary of the activity in stock options and related information is as follows:

	Number of options			Weighted average exercise price		Weighted average remaining contractual term in years		Aggregate intrinsic Value
Outstanding as of December 31, 2022		339,029		$	50.64		4.86	$	79,414
Exercised		(3,645	)		20.46		-		1,073
Outstanding as of March 31, 2023		335,384		$	50.97		4.63	$	84,989
Vested and expected to vest as of March 31, 2023		334,950		$	50.80		4.62	$	84,937
Exercisable as of March 31, 2023		311,240		$	40.47		4.43	$	82,079

The aggregate intrinsic value in the tables above represents the total intrinsic value (the difference between the fair value of the Company’s common stock as of the last day of each period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last day of each period.

A summary of the activity in the RSUs and related information is as follows:

	Number of RSUs			Weighted average grant date fair value
Unvested as of December 31, 2022		1,488,515		$	232.05
Granted		103,081			296.64
Vested		(197,866	)		164.31
Forfeited		(31,296	)		254.24
Unvested as of March 31, 2023		1,362,434		$	246.27

A summary of the activity in the PSUs and related information is as follows:

	Number of PSUs			Weighted average grant date fair value
Unvested as of December 31, 2022		149,232		$	295.88
Granted		31,911			314.22
Vested		(8,249	)		270.93
Unvested as of March 31, 2023		172,894		$	300.45

d. Employee Stock Purchase Plan ("ESPP"):

The Company adopted an ESPP effective upon the consummation of the IPO. As of March 31, 2023, a total of 4,150,380 shares were reserved for issuance under this plan. The number of shares of common stock reserved for issuance under the ESPP will increase automatically on January 1^st of each year, for ten years, by the lesser of 1% of the total number of shares of the Company’s common stock outstanding on December 31st of the preceding calendar year or 487,643 shares. However, the Company’s board of directors may reduce the amount of the increase in any particular year at their discretion, including a reduction to zero.

The ESPP is implemented through an offering every six months. According to the ESPP, eligible employees may use up to 15% of their salaries to purchase common stock up to an aggregate limit of $15 per participant for every six months plan. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the subscription date of each offering period or on the purchase date.

As of March 31, 2023, 738,876 shares of common stock had been purchased under the ESPP.

As of March 31, 2023, 3,411,504 shares of common stock were available for future issuance under the ESPP.

In accordance with ASC No. 718, the ESPP is compensatory and, as such, results in recognition of compensation cost.

e. Stock-based compensation expenses:

The Company recognized stock-based compensation expenses related to all stock-based awards in the condensed consolidated statement of income for the three months ended March 31, 2023, and 2022, as follows:

	Three Months Ended March 31,
	2023		2022
Cost of revenues	$	5,927	$	5,062
Research and development		17,209		14,985
Selling and marketing		8,079		6,701
General and administrative		8,020		7,359
Total stock-based compensation expenses	$	39,235	$	34,107

For the three months ended March 31, 2023, the Company capitalized stock-based compensation expenses in the amount of $430 related to ERP implementation, which were included within other long-term assets in the condensed consolidated balance sheets and $405 related to inventory.

For the three months ended March 31, 2022, the Company did not capitalize any stock-based compensation expenses.

The total tax benefit associated with share-based compensation for the three months ended March 31, 2023 and 2022 was $4,197 and $3,478, respectively. The tax benefit realized from share-based compensation for three months ended March 31, 2023 and 2022 was $2,842 and $2,927, respectively.

As of March 31, 2023, there were total unrecognized compensation expenses in the amount of $335,864 related to non-vested equity-based compensation arrangements granted. These expenses are expected to be recognized during the period from April 1, 2023 through February 28, 2027.

XML

COMMITMENTS AND CONTINGENT LIABILITIES

3 Months Ended

Mar. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENT LIABILITIES

NOTE 12:     COMMITMENTS AND CONTINGENT LIABILITIES

a. Guarantees:

As of March 31, 2023, contingent liabilities exist regarding guarantees in the amounts of $5,876, and $1,899 in respect of office rent lease agreements and customs and other transactions, respectively.

b. Contractual purchase obligations:

The Company has contractual obligations to purchase goods and raw materials. These contractual purchase obligations relate to inventories and other purchase orders, which cannot be canceled without penalty. In addition, the Company acquires raw materials or other goods and services, including product components, by issuing authorizations to its suppliers to purchase materials based on its projected demand and manufacturing needs.

As of March 31, 2023, the Company had non-cancelable purchase obligations totaling approximately $1,617,376, out of which the Company recorded a provision for loss in the amount of $8,052.

As of March 31, 2023, the Company had contractual obligations for capital expenditures totaling approximately $121,347. These commitments reflect purchases of automated assembly lines and other machinery related to the Company’s general manufacturing process and mainly to its plans to establish manufacturing capabilities in the United States.

c.  Legal claims:

From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular matter.

In September 2018, the Company’s German subsidiary, SolarEdge Technologies GmbH, received a complaint filed by competitor SMA Solar Technology AG (“SMA”). The complaint, filed in the District Court Düsseldorf, Germany, alleges that SolarEdge's 12.5kW - 27.6kW inverters infringed on two of the plaintiff’s patents. SMA asserted a value in dispute of EUR 5.5 million (approximately $5,983) for both patents. The Company challenged the validity of both patents and the first patent was invalidated and SMA’s appeal on the matter was denied in January 2023. In August 2021, the German Patent Court rendered SMA's second patent invalid, and this invalidity has been appealed by SMA and a hearing is pending. The Company believes that it has meritorious defenses to these claims and intends to vigorously defend against the remaining lawsuit.

On July 28, 2022, the Company was served with complaints filed by Ampt LLC in the International Trade Commission (the “Commission”) pursuant to Section 337 of the Tariff Act of 1930, as amended, in the District Court for the District of Delaware alleging patent infringement against the Company and its subsidiary SolarEdge Technologies Ltd. On October 24, 2022, the complaint filed in the District Court of Delaware was administratively stayed until the Commission's action is resolved. The Company believes that it has meritorious defenses to the complaints and intend to vigorously defend against them.

As of March 31, 2023, an immaterial amount for legal claims was recorded in accrued expenses and other current liabilities.

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS

3 Months Ended

Mar. 31, 2023

Accumulated Other Comprehensive Income Loss [Abstract]

ACCUMULATED OTHER COMPREHENSIVE LOSS

NOTE 13:       ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table summarizes the changes in accumulated balances of other comprehensive gain (loss), net of taxes:

	Three Months Ended March 31,
	2023			2022
Unrealized gains (losses) on available-for-sale marketable securities
Beginning balance	$	(25,449	)	$	(4,709	)
Revaluation		7,570			(12,721	)
Tax on revaluation		(1,471	)		2,471
Other comprehensive income (loss) before reclassifications		6,099			(10,250	)
Reclassification		107			844
Tax on reclassification		(29	)		(100	)
Losses reclassified from accumulated other comprehensive income		78			744
Net current period other comprehensive income (loss)		6,177			(9,506	)
Ending balance	$	(19,272	)	$	(14,215	)
Unrealized gains (losses) on cash flow hedges
Beginning balance	$	(1,761	)	$	874
Revaluation		(2,196	)		(1,337	)
Tax on revaluation		139			159
Other comprehensive loss before reclassifications		(2,057	)		(1,178	)
Reclassification		1,840			565
Tax on reclassification		(114	)		(67	)
Losses reclassified from accumulated other comprehensive loss		1,726			498
Net current period other comprehensive loss		(331	)		(680	)
Ending balance	$	(2,092	)	$	194
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment in nature
Beginning balance	$	(37,960	)	$	(17,420	)
Revaluation		(10,800	)		(6,983	)
Ending balance	$	(48,760	)	$	(24,403	)
Unrealized gains (losses) on foreign currency translation
Beginning balance	$	(7,939	)	$	(6,064	)
Revaluation		859			(1,579	)
Ending balance	$	(7,080	)	$	(7,643	)
Total	$	(77,204	)	$	(46,067	)

The following table summarizes the reclassifications from "Accumulated other comprehensive loss" into the statement of income:

Details about Accumulated Other Comprehensive Loss Components	Three Months Ended March 31,						Affected Line Item in the Statement of Income
	2023			2022
Available-for-sale marketable securities
	$	(107	)	$	(844)		Financial income (expense), net
		29			100		Income taxes
	$	(78	)	$	(744)		Total, net of income taxes
Cash flow hedges
		(212	)		(67	)	Cost of revenues
		(1,129	)		(338	)	Research and development
		(225	)		(71	)	Sales and marketing
		(274	)		(89	)	General and administrative
	$	(1,840	)	$	(565)		Total, before income taxes
		114			67		Income taxes
		(1,726	)		(498	)	Total, net of income taxes
Total reclassifications for the period	$	(1,804	)	$	(1,242)

XML

OTHER OPERATING INCOME

3 Months Ended

Mar. 31, 2023

Other Income and Expenses [Abstract]

OTHER OPERATING INCOME

NOTE 14:       OTHER OPERATING INCOME

In the three months ended March 31, 2023, the Company recorded a gain from sale of property, plant and equipment and other assets in the amount of $1,434.

XML

INCOME TAXES

3 Months Ended

Mar. 31, 2023

Income Taxes

INCOME TAXES

NOTE 15:       INCOME TAXES

The effective tax rate for the three months ended March 31, 2023, and 2022 was 17.5% and 27.1%, respectively.

The lower tax rate in the current quarter compared to the first quarter of 2022 is mainly due to the fact that the Company's income before tax, most of which is subject to tax rates lower than the US statutory rate, increased. Conversely, the IRC Section 174 R&D capitalization, and other expenses not recognized for GILTI purposes, did not increase in the same proportion.

As of March 31, 2023, and December 31, 2022, unrecognized tax benefits were $2,883 and $2,756, respectively. If recognized, such benefits would favorably affect the Company’s effective tax rate.

The Company accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes. The total amount of penalties and interest were immaterial as of March 31, 2023, and December 31, 2022.

In August 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the “IRA”), which includes several incentives intended to promote clean energy, battery and energy storage, electrical vehicles, and other solar products, and is expected to impact our business and operations. As part of such incentives the IRA, will among other things, extend the investment tax credit (“ITC”) through 2034 and is therefore expected to increase the demand for solar products. The IRA is expected to further incentivize residential and commercial solar customers and developers due to the inclusion of a tax credit for qualifying energy projects of up to 30%. Since these regulations are new and their implementation is still pending administrative guidance from the Internal Revenue Service and U.S. Treasury Department, the Company will be examining the benefits that may be available to it, such as the availability of tax credits for domestic manufacturers, in the coming months. The Company also announced its plans to establish manufacturing capabilities in the United States during 2023.

XML

EARNINGS PER SHARE

3 Months Ended

Mar. 31, 2023

Net income per share:

EARNINGS PER SHARE

NOTE 16:       EARNINGS PER SHARE

The following table presents the computation of basic and diluted earnings per share (“EPS”):

	Three Months Ended March 31,
	2023		2022
Basic EPS:
Numerator:
Net income	$	138,378	$	33,123
Denominator:
Shares used in computing net earnings per share of common stock, basic		56,215,490		53,134,937
Diluted EPS:
Numerator:
Net income attributable to common stock, basic	$	138,378	$	33,123
Notes due 2025		552		553
Net income attributable to common stock, diluted	$	138,930	$	33,676
Denominator:
Shares used in computing net earnings per share of common stock, basic		56,215,490		53,134,937
Notes due 2025		2,276,818		2,276,818
Effect of stock-based awards		701,523		903,438
Shares used in computing net earnings per share of common stock, diluted		59,193,831		56,315,193
Earnings per share:
Basic	$	2.46	$	0.62
Diluted	$	2.35	$	0.60
Shares excluded from the calculation of diluted net EPS due to their anti-dilutive effect		192,339		223,776

XML

SEGMENT INFORMATION

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

SEGMENT INFORMATION

NOTE 17:      SEGMENT INFORMATION

Following the discontinuation of Critical Power in June 2022, the Company operates in four different operating segments: Solar, Energy Storage, e-Mobility and Automation Machines.

The Company’s Chief Executive Officer, who is the chief operating decision maker (“CODM”), makes resource allocation decisions and assesses performance based on financial information presented on a consolidated basis, accompanied by disaggregated information about revenues and contributed profit by the operating segments.

The Company does not allocate to its operating segments revenue recognized due to advance payments received for performance obligations that extend for a period greater than one year, related to Accounting Standard Codification 606, “Revenue from Contracts with Customers” (ASC 606).

Segment profit is comprised of gross profit for the segment less operating expenses that do not include amortization of purchased intangible assets, impairments of goodwill and intangible assets, stock based compensation expenses, and certain other items.

The Company manages its assets on a group basis, not by segments, as many of its assets are shared or co-mingled. The Company’s CODM does not regularly review asset information by segments and, therefore, the Company does not report asset information by segment.

The Company identified one operating segment as reportable – the Solar segment. The other operating segments are insignificant individually and therefore their results are presented together under “All other”.

The Solar segment includes the design, development, manufacturing, and sales of an intelligent inverter solution designed to maximize power generation at the individual PV module level and a residential storage solution, compatible with the Company’s Energy Hub inverter, intended to store and supply power for back-up and to maximize self-consumption. The Solar segment solution consists mainly of the Company’s power optimizers, inverters, batteries, and cloud‑based monitoring platform.

The “All other” category includes the design, development, manufacturing, and sales of energy storage products, e-Mobility products, UPS products, and automated machines.

The following table presents information on reportable segments profit (loss) for the period presented:

	Three Months Ended March 31,
	2023					2022
	Solar		All other			Solar		All other
Revenues	$	908,505	$	35,197		$	607,997	$	46,948
Cost of revenues		590,105		46,216			424,500		44,341
Gross profit (loss)		318,400		(11,019	)		183,497		2,607
Research and development	$	55,823	$	6,528		$	43,131	$	7,930
Sales and marketing		31,145		1,561			25,805		2,574
General and administrative		24,743		3,778			15,849		3,625
Segments profit (loss)	$	206,689	$	(22,886	)	$	98,712	$	(11,522	)

The following table presents information on reportable segments reconciliation to consolidated revenues for the periods presented:

	Three Months Ended March 31,
	2023		2022
Solar revenues	$	908,505	$	607,997
All other segment revenues		35,197		46,948
Revenues from financing component		187		135
Consolidated revenues	$	943,889	$	655,080

The following table presents information on reportable segments reconciliation to consolidated operating income for the periods presented:

	Three Months Ended March 31,
	2023			2022
Solar segment profit	$	206,689		$	98,712
All other segment loss		(22,886	)		(11,522	)
Segments operating profit		183,803			87,190
Amounts not allocated to segments:
Stock based compensation expenses		(39,235	)		(34,107	)
Other unallocated expenses		(414	)		(2,219	)
Consolidated operating income	$	144,154		$	50,864

XML

SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2023

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 18:      SUBSEQUENT EVENTS

On April 6, 2023, the Company completed the acquisition of all outstanding shares of Hark Systems Ltd. ("Hark"), a UK-based energy IoT company for the commercial and industrial ("C&I") sector for approximately USD 16.7 million in cash. Hark's platform is expected to enable the Company to offer its commercial and industrial customers expanded capabilities in energy management and connectivity, including identification of potential energy savings, detection of anomalies in assets’ energy consumption, and optimization of energy usage and carbon emissions through load orchestration and storage control.

XML

GENERAL (Policies)

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

c. Basis of Presentation:

The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. The Company’s interim period results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year.

The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2022, contained in the Company’s Annual Report on Form 10-K filed with the SEC on February 22, 2023, have been applied consistently in these unaudited interim condensed consolidated financial statements. Certain prior year amounts have been reclassified to conform to current year presentation.

Use of estimates

d. Use of estimates:

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes. The duration, scope and effects of the ongoing Covid-19 pandemic and the conflict in Ukraine, government and other third-party responses to it, and the related macroeconomic effects, including to the Company’s business and the business of the Company’s suppliers and customers are uncertain, rapidly changing and difficult to predict. As a result, the Company’s accounting estimates and assumptions may change over time in response to this evolving situation. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, inventories, incremental credit losses on receivables and available-for-sale marketable debt securities, or an increase in the Company’s insurance liabilities as of the time of a relevant measurement event.

Concentrations of supply risks

e. Concentrations of supply risks:

The Company depends on two contract manufacturers and several limited or single source component suppliers. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields, and costs.

As of March 31, 2023, and December 31, 2022, two contract manufacturers collectively accounted for 31.3% and 34.3% of the Company’s total trade payables, net, respectively.

In the second quarter of 2022, the Company announced the opening of “Sella 2”, a two gigawatt-hour (GWh) Li-Ion battery cell manufacturing facility located in South Korea. Sella 2 began producing and shipping cells at the end of 2022 and is expected to reach full manufacturing capacity in 2023. Sella 2 is the Company's second owned manufacturing facility following the establishment of Sella 1 in 2020. Sella 1 is the Company's manufacturing facility in the North of Israel that produces power optimizers and inverters for the Company's solar activities.

New accounting standards updates

f. New accounting standards updates:

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") or other standard setting bodies are adopted by the Company as of the specified effective date. The Company believes that the impact of recently issued or newly effective standards were not applicable to the Company, did not have a material impact on the condensed consolidated financial statements or are not expected to have a material impact on the condensed consolidated financial statements.

XML

MARKETABLE SECURITIES (Tables)

3 Months Ended

Mar. 31, 2023

Marketable Securities [Abstract]

Schedule of available-for-sale marketable securities

The following is a summary of available-for-sale marketable securities as of March 31, 2023:

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale – matures within one year:
Corporate bonds	$	390,012	$	82	$	(8,595	)	$	381,499
Governmental bonds		29,788		-		(467	)		29,321
		419,800		82		(9,062	)		410,820
Available-for-sale – matures after one year:
Corporate bonds		515,425		698		(15,855	)		500,268
Governmental bonds		9,251		-		(392	)		8,859
		524,676		698		(16,247	)		509,127
Total	$	944,476	$	780	$	(25,309	)	$	919,947

The following is a summary of available-for-sale marketable securities as of December 31, 2022:

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Available-for-sale – matures within one year:
Corporate bonds	$	222,482	$	-	$	(4,657	)	$	217,825
Governmental bonds		23,845		-		(553	)		23,292
		246,327		-		(5,210	)		241,117
Available-for-sale – matures after one year:
Corporate bonds		657,238		80		(26,460	)		630,858
Governmental bonds		15,250		-		(617	)		14,633
		672,488		80		(27,077	)		645,491
Total	$	918,815	$	80	$	(32,287	)	$	886,608

XML

INVENTORIES, NET (Tables)

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Schedule of Inventories, Net

	March 31, 2023		December 31, 2022
Raw materials	$	503,445	$	503,257
Work in process		37,754		23,407
Finished goods		333,013		202,537
Total inventories, net	$	874,212	$	729,201

XML

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)

3 Months Ended

Mar. 31, 2023

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

	March 31, 2023		December 31, 2022
Vendor non-trade receivables (*)	$	147,238	$	147,597
Government authorities		57,275		55,670
Prepaid expenses and other		55,129		37,815
Total prepaid expenses and other current assets	$	259,642	$	241,082

(*) Vendor non-trade receivables derived from the sale of components to manufacturing vendors who manufacture products for the Company. The Company purchases these components directly from other suppliers. The Company does not reflect the sale of these components to the contract manufacturers in its revenues.

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)

3 Months Ended

Mar. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of fair values of outstanding derivative instruments

	Balance sheet location	March 31, 2023			December 31, 2022
Derivative assets of options and forward contracts:
Designated cash flow hedges	Prepaid expenses and other current assets	$	353		$	-
Derivative liabilities of options and forward contracts:
Designated cash flow hedges	Accrued expenses and other current liabilities	$	(2,583	)	$	(1,874	)

Schedule of gains (losses) on derivative instruments recognized in our income statements

		Three Months Ended March 31,
	Affected line item	2023			2022
Foreign exchange contracts
Non Designated Hedging Instruments	Condensed Consolidated Statements of Income - Financial income (expense), net	$	-		$	934
Designated Hedging Instruments	Condensed Consolidated Statements of Comprehensive Income - Cash flow hedges	$	(2,057	)	$	(1,178	)

XML

FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of assets and liabilities measured at fair value

	Fair Value Hierarchy	Fair value measurements as of
Description		March 31, 2023			December 31, 2022
Assets:
Cash and cash equivalents:
Cash	Level 1	$	667,384		$	695,004
Money market mutual funds	Level 1	$	17,486		$	25,149
Deposits	Level 1	$	42,979		$	62,959
Derivative instruments	Level 2	$	353		$	-
Short-term marketable securities:
Corporate bonds	Level 2	$	381,499		$	217,825
Governmental bonds	Level 2	$	29,321		$	23,292
Long-term marketable securities:
Corporate bonds	Level 2	$	500,268		$	630,858
Governmental bonds	Level 2	$	8,859		$	14,633
Liabilities:
Derivative instruments	Level 2	$	(2,583	)	$	(1,874	)

XML

WARRANTY OBLIGATIONS (Tables)

3 Months Ended

Mar. 31, 2023

Product Warranties Disclosures [Abstract]

Schedule of warranty obligations

	Three Months Ended March 31,
	2023			2022
Balance, at the beginning of the period	$	385,057		$	265,160
Additions and adjustments to cost of revenues		91,570			47,907
Usage and current warranty expenses		(33,656	)		(20,401	)
Balance, at end of the period		442,971			292,666
Less current portion		(129,278	)		(82,340	)
Long term portion	$	313,693		$	210,326

XML

DEFERRED REVENUES AND CUSTOMERS ADVANCES (Tables)

3 Months Ended

Mar. 31, 2023

Revenue Recognition and Deferred Revenue [Abstract]

Schedule of balances of deferred revenues

	Three Months Ended March 31,
	2023			2022
Balance, at the beginning of the period	$	213,577		$	169,345
Revenue recognized		(11,742	)		(14,529	)
Increase in deferred revenues and customer advances		22,589			29,429
Balance, at the end of the period		224,424			184,245
Less current portion		(27,507	)		(25,511	)
Long term portion	$	196,917		$	158,734

Schedule estimated revenues expected to recognized in future to performance obligations

2023	$	23,888
2024		12,073
2025		10,764
2026		10,389
2027		8,363
Thereafter		158,947
Total deferred revenues	$	224,424

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)

3 Months Ended

Mar. 31, 2023

Payables and Accruals [Abstract]

Schedule of accrued expenses and other current liabilities

	March 31, 2023		December 31, 2022
Accrued expenses	$	127,018	$	117,638
Government authorities		87,159		67,514
Operating lease liabilities		17,215		16,183
Accrual for sales incentives		5,746		6,790
Other		6,743		5,987
Total accrued expenses and other current liabilities	$	243,881	$	214,112

XML

CONVERTIBLE SENIOR NOTES (Tables)

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Schedule of convertible senior notes

	March 31, 2023			December 31, 2022
Liability:
Principal	$	632,500		$	632,500
Unamortized issuance costs		(7,318	)		(8,049	)
Net carrying amount	$	625,182		$	624,451

XML

STOCK CAPITAL (Tables)

3 Months Ended

Mar. 31, 2023

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of activity in the share options granted to employees and members of board of directors

	Number of options			Weighted average exercise price		Weighted average remaining contractual term in years		Aggregate intrinsic Value
Outstanding as of December 31, 2022		339,029		$	50.64		4.86	$	79,414
Exercised		(3,645	)		20.46		-		1,073
Outstanding as of March 31, 2023		335,384		$	50.97		4.63	$	84,989
Vested and expected to vest as of March 31, 2023		334,950		$	50.80		4.62	$	84,937
Exercisable as of March 31, 2023		311,240		$	40.47		4.43	$	82,079

Schedule of RSU activity

	Number of RSUs			Weighted average grant date fair value
Unvested as of December 31, 2022		1,488,515		$	232.05
Granted		103,081			296.64
Vested		(197,866	)		164.31
Forfeited		(31,296	)		254.24
Unvested as of March 31, 2023		1,362,434		$	246.27

Schedule of recognized stock-based compensation expenses

	Three Months Ended March 31,
	2023		2022
Cost of revenues	$	5,927	$	5,062
Research and development		17,209		14,985
Selling and marketing		8,079		6,701
General and administrative		8,020		7,359
Total stock-based compensation expenses	$	39,235	$	34,107

Option [Member] | Employees and members of board of directors

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of RSU activity

	Number of PSUs			Weighted average grant date fair value
Unvested as of December 31, 2022		149,232		$	295.88
Granted		31,911			314.22
Vested		(8,249	)		270.93
Unvested as of March 31, 2023		172,894		$	300.45

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

3 Months Ended

Mar. 31, 2023

Accumulated Other Comprehensive Income Loss [Abstract]

Schedule of changes in AOCI

	Three Months Ended March 31,
	2023			2022
Unrealized gains (losses) on available-for-sale marketable securities
Beginning balance	$	(25,449	)	$	(4,709	)
Revaluation		7,570			(12,721	)
Tax on revaluation		(1,471	)		2,471
Other comprehensive income (loss) before reclassifications		6,099			(10,250	)
Reclassification		107			844
Tax on reclassification		(29	)		(100	)
Losses reclassified from accumulated other comprehensive income		78			744
Net current period other comprehensive income (loss)		6,177			(9,506	)
Ending balance	$	(19,272	)	$	(14,215	)
Unrealized gains (losses) on cash flow hedges
Beginning balance	$	(1,761	)	$	874
Revaluation		(2,196	)		(1,337	)
Tax on revaluation		139			159
Other comprehensive loss before reclassifications		(2,057	)		(1,178	)
Reclassification		1,840			565
Tax on reclassification		(114	)		(67	)
Losses reclassified from accumulated other comprehensive loss		1,726			498
Net current period other comprehensive loss		(331	)		(680	)
Ending balance	$	(2,092	)	$	194
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment in nature
Beginning balance	$	(37,960	)	$	(17,420	)
Revaluation		(10,800	)		(6,983	)
Ending balance	$	(48,760	)	$	(24,403	)
Unrealized gains (losses) on foreign currency translation
Beginning balance	$	(7,939	)	$	(6,064	)
Revaluation		859			(1,579	)
Ending balance	$	(7,080	)	$	(7,643	)
Total	$	(77,204	)	$	(46,067	)

Schedule of reclassifications out of AOCI

Details about Accumulated Other Comprehensive Loss Components	Three Months Ended March 31,						Affected Line Item in the Statement of Income
	2023			2022
Available-for-sale marketable securities
	$	(107	)	$	(844)		Financial income (expense), net
		29			100		Income taxes
	$	(78	)	$	(744)		Total, net of income taxes
Cash flow hedges
		(212	)		(67	)	Cost of revenues
		(1,129	)		(338	)	Research and development
		(225	)		(71	)	Sales and marketing
		(274	)		(89	)	General and administrative
	$	(1,840	)	$	(565)		Total, before income taxes
		114			67		Income taxes
		(1,726	)		(498	)	Total, net of income taxes
Total reclassifications for the period	$	(1,804	)	$	(1,242)

XML

EARNINGS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2023

Net income per share:

Schedule of computation of basic and diluted net earnings (loss) per share

	Three Months Ended March 31,
	2023		2022
Basic EPS:
Numerator:
Net income	$	138,378	$	33,123
Denominator:
Shares used in computing net earnings per share of common stock, basic		56,215,490		53,134,937
Diluted EPS:
Numerator:
Net income attributable to common stock, basic	$	138,378	$	33,123
Notes due 2025		552		553
Net income attributable to common stock, diluted	$	138,930	$	33,676
Denominator:
Shares used in computing net earnings per share of common stock, basic		56,215,490		53,134,937
Notes due 2025		2,276,818		2,276,818
Effect of stock-based awards		701,523		903,438
Shares used in computing net earnings per share of common stock, diluted		59,193,831		56,315,193
Earnings per share:
Basic	$	2.46	$	0.62
Diluted	$	2.35	$	0.60
Shares excluded from the calculation of diluted net EPS due to their anti-dilutive effect		192,339		223,776

XML

SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Schedule of reportable segments and operating income

	Three Months Ended March 31,
	2023					2022
	Solar		All other			Solar		All other
Revenues	$	908,505	$	35,197		$	607,997	$	46,948
Cost of revenues		590,105		46,216			424,500		44,341
Gross profit (loss)		318,400		(11,019	)		183,497		2,607
Research and development	$	55,823	$	6,528		$	43,131	$	7,930
Sales and marketing		31,145		1,561			25,805		2,574
General and administrative		24,743		3,778			15,849		3,625
Segments profit (loss)	$	206,689	$	(22,886	)	$	98,712	$	(11,522	)

Schedule of reconciliation to consolidated operating income

The following table presents information on reportable segments reconciliation to consolidated revenues for the periods presented:

	Three Months Ended March 31,
	2023		2022
Solar revenues	$	908,505	$	607,997
All other segment revenues		35,197		46,948
Revenues from financing component		187		135
Consolidated revenues	$	943,889	$	655,080

The following table presents information on reportable segments reconciliation to consolidated operating income for the periods presented:

	Three Months Ended March 31,
	2023			2022
Solar segment profit	$	206,689		$	98,712
All other segment loss		(22,886	)		(11,522	)
Segments operating profit		183,803			87,190
Amounts not allocated to segments:
Stock based compensation expenses		(39,235	)		(34,107	)
Other unallocated expenses		(414	)		(2,219	)
Consolidated operating income	$	144,154		$	50,864

XML

GENERAL (Narrative) (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounts Payable [Member] | Supplier Concentration Risk [Member]
Organization Consolidation and Presentation of Financial Statements [Line Items]
Concentration Risk As Percent	31.30%	34.30%

XML

MARKETABLE SECURITIES (Schedule of AFS Marketable Debt Securities) (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Available-for-sale - matures within one year, Amortized cost	$ 419,800	$ 246,327
Available-for-sale - matures within one year, Gross unrealized gains	82	0
Available-for-sale - matures within one year, Gross unrealized losses	(9,062)	(5,210)
Available-for-sale - matures within one year, Fair value	410,820	241,117
Available-for-sale - matures after one year, Amortized cost	524,676	672,488
Available-for-sale - matures after one year, Gross unrealized gains	698	80
Available-for-sale - matures after one year, Gross unrealized losses	(16,247)	(27,077)
Available-for-sale - matures after one year, Fair value	509,127	645,491
Amortized cost	944,476	918,815
Gross unrealized gains	780	80
Gross unrealized losses	(25,309)	(32,287)
Fair value	919,947	886,608
Corporate bonds [Member]
Available-for-sale - matures within one year, Amortized cost	390,012	222,482
Available-for-sale - matures within one year, Gross unrealized gains	82	0
Available-for-sale - matures within one year, Gross unrealized losses	(8,595)	(4,657)
Available-for-sale - matures within one year, Fair value	381,499	217,825
Available-for-sale - matures after one year, Amortized cost	515,425	657,238
Available-for-sale - matures after one year, Gross unrealized gains	698	80
Available-for-sale - matures after one year, Gross unrealized losses	(15,855)	(26,460)
Available-for-sale - matures after one year, Fair value	500,268	630,858
Governmental bonds [Member]
Available-for-sale - matures within one year, Amortized cost	29,788	23,845
Available-for-sale - matures within one year, Gross unrealized gains	0	0
Available-for-sale - matures within one year, Gross unrealized losses	(467)	(553)
Available-for-sale - matures within one year, Fair value	29,321	23,292
Available-for-sale - matures after one year, Amortized cost	9,251	15,250
Available-for-sale - matures after one year, Gross unrealized gains	0	0
Available-for-sale - matures after one year, Gross unrealized losses	(392)	(617)
Available-for-sale - matures after one year, Fair value	$ 8,859	$ 14,633

XML

INVENTORIES, NET (Schedule of Inventories, Net) (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 503,445	$ 503,257
Work in process	37,754	23,407
Finished goods	333,013	202,537
Total inventories, net	$ 874,212	$ 729,201

XML

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($) $ in Thousands		Mar. 31, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Vendor non-trade receivables	[1]	$ 147,238	$ 147,597
Government authorities		57,275	55,670
Prepaid expenses and other		55,129	37,815
Total prepaid expenses and other current assets		$ 259,642	$ 241,082

[1] Vendor non-trade receivables derived from the sale of components to manufacturing vendors who manufacture products for the Company. The Company purchases these components directly from other suppliers. The Company does not reflect the sale of these components to the contract manufacturers in its revenues.

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Narrative) (Details) - Foreign exchange forward contracts [Member] - NIS [Member] ₪ in Millions	Mar. 31, 2023 ILS (₪)
Put option [Member]
Derivative [Line Items]
Forward/option contracts	₪ 231
Call option [Member]
Derivative [Line Items]
Forward/option contracts	₪ 125

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of fair values of outstanding derivative instruments) (Details) - Designated cash flow hedges [Member] - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Derivative assets of options and forward contracts:
Total derivative assets	$ 353	$ 0
Derivative liabilities of options and forward contracts:
Total derivative liabilities	$ (2,583)	$ (1,874)

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Gains (losses) on derivative instruments recognized in our income statements) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Designated Hedging Instruments [Member]
Trading Activity, Gains and Losses, Net [Line Items]
Gains (losses) on derivative instruments	$ (2,057)	$ (1,178)
Non Designated Hedging Instruments [Member]
Trading Activity, Gains and Losses, Net [Line Items]
Gains (losses) on derivative instruments	$ 0	$ 934

XML

FAIR VALUE MEASUREMENTS (Schedule of Assets Measured at Fair Value) (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Level 1 [Member] | Cash [Member]
Fair value of assets	$ 667,384	$ 695,004
Level 1 [Member] | Money Market Mutual Funds [Member]
Fair value of assets	17,486	25,149
Level 1 [Member] | Deposits [Member]
Fair value of assets	42,979	62,959
Level 2 [Member] | Derivative instruments, Liabilities [Member]
Fair value of liabilities	(2,583)	(1,874)
Level 2 [Member] | Derivative instruments, Assets [Member]
Fair value of assets	353	0
Level 2 [Member] | Short-term Corporate bonds [Member]
Fair value of assets	381,499	217,825
Level 2 [Member] | Short-term Governmental bonds [Member]
Fair value of assets	29,321	23,292
Level 2 [Member] | Long-term Corporate bonds [Member]
Fair value of assets	500,268	630,858
Level 2 [Member] | Long-term Governmental bonds [Member]
Fair value of assets	$ 8,859	$ 14,633

XML

WARRANTY OBLIGATIONS (Schedule of product warranty obligations) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Changes in the Company's product warranty liability
Balance, at the beginning of the period	$ 385,057	$ 265,160
Additions and adjustments to cost of revenues	91,570	47,907
Usage and current warranty expenses	(33,656)	(20,401)
Balance, at end of the period	442,971	292,666
Less current portion	(129,278)	(82,340)	$ (103,975)
Long term portion	$ 313,693	$ 210,326	$ 281,082

XML

DEFERRED REVENUES AND CUSTOMERS ADVANCES (Schedule of Balances of deferred revenues and customer advances) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue Recognition and Deferred Revenue [Abstract]
Balance, at the beginning of the period	$ 213,577	$ 169,345
Revenue recognized	(11,742)	(14,529)
Increase in deferred revenues and customer advances	22,589	29,429
Balance, at the end of the period	224,424	184,245
Less current portion	(27,507)	(25,511)
Long term portion	$ 196,917	$ 158,734

XML

DEFERRED REVENUES AND CUSTOMERS ADVANCES (Schedule Estimated Revenues Expected To Recognized In Future To Performance Obligations) (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Deferred revenues	$ 224,424	$ 213,577	$ 184,245	$ 169,345
2023 [Member]
Deferred revenues	23,888
2024 [Member]
Deferred revenues	12,073
2025 [Member]
Deferred revenues	10,764
2026 [Member]
Deferred revenues	10,389
2027 [Member]
Deferred revenues	8,363
Thereafter [Member]
Deferred revenues	$ 158,947

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Schedule of Accrued Expenses and Other Current Liabilities) (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued expenses	$ 127,018	$ 117,638
Government authorities	87,159	67,514
Operating lease liabilities	17,215	16,183
Accrual for sales incentives	5,746	6,790
Other	6,743	5,987
Total accrued expenses and other current liabilities	$ 243,881	$ 214,112

XML

CONVERTIBLE SENIOR NOTES (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended
	Sep. 25, 2020	Mar. 31, 2023	Mar. 31, 2022
Convertible Senior Notes due 2025 [Member]
Debt Instrument [Line Items]
Debt conversion description		On September 25, 2020, the Company sold $632,500 aggregate principal amount of its 0.00% convertible senior notes due 2025 (the “Notes”). The Notes were sold pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes do not bear regular interest and mature on September 15, 2025, unless earlier repurchased or converted in accordance with their terms. The Notes are general senior unsecured obligations of the Company. Holders may convert their Notes prior to the close of business on the business day immediately preceding June 15, 2025 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2020 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five-business-day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each trading day of that five consecutive trading day period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events as described in the Indenture. In addition, holders may convert their Notes, in multiples of $1,000 principal amount, at their option at any time beginning on or after June 15, 2025, and prior to the close of business on the second scheduled trading day immediately preceding the stated maturity date of the Notes, without regard to the foregoing circumstances. The initial conversion rate for the Notes was 3.5997 shares of common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $277.80 per share of common stock, subject to adjustment upon the occurrence of certain specified events as set forth in the Indenture.
Principal amount sold	$ 632,500
Effective coupon rate	0.00%
Maturity date	Sep. 15, 2025
Conversion amount	$ 1,000
Number of shares of common stock per $1,000 principal amount of Notes converted	3.5997
Amount of conversion	$ 1,000
Conversion price	$ 277.8
Amortization of debt discount and debt issuance costs		$ 731	$ 728
Amortized period		2 years 6 months
Effective interest		0.47%
Amount by which the if-converted value of the Notes exceeded the principal amount		$ 59,537
Senior Notes [Member] | Level 2 [Member]
Debt Instrument [Line Items]
Estimated fair value of notes		$ 823,730

XML

CONVERTIBLE SENIOR NOTES (Schedule of Convertible Senior Notes) (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Liability Abstract
Net carrying amount	$ 625,182	$ 624,451
Convertible Senior Notes [Member]
Liability Abstract
Principal	632,500	632,500
Unamortized issuance costs	(7,318)	(8,049)
Net carrying amount	$ 625,182	$ 624,451

XML

STOCK CAPITAL (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended
	Mar. 17, 2022	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from secondary public offering, net of issuance costs		$ 0	$ 650,526
Underwriters discounts and commissions			27,140
Offering costs			834
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan		10,000,000
Equity based compensation expenses to employees and nonemployees		$ 4,197	3,478
Capitalized stock-based compensation expenses related to ERP		430
Inventory		405
Tax benefit realized from share-based compensation		2,842	$ 2,927
Unrecognized compensation expense		$ 335,864
IPO [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock shares sold in public offerings	2,300,000
Per share price of common stock sold	$ 295
IPO [Member] | Underwriting Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock shares sold in public offerings	300,000
Proceeds from secondary public offering, net of issuance costs	$ 650,526
Underwriters discounts and commissions	27,140
Offering costs	$ 834
Option [Member] | Two Thousand Seven Global Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan		20,853,755
Number of shares available for future grant under the plan		12,005,195
Option [Member] | Two Thousand Fifteen Global Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage Of Common Shares Increase Automatically Each Year		5.00%
Number of shares available for future grant under the plan		8,617,974		379,358
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan		4,150,380
Percentage Of Common Shares Increase Automatically Each Year		1.00%
Period Of Plan Increase Automatically Number Of Shares		487,643
Maximum Percentage Of Salary		15.00%
Aggregate Limit Per Participant		$ 15
Purchase price of common stock, percent		85.00%
Number of Common stock purchased		738,876
Number of shares available for future grant under the plan		3,411,504

XML

STOCK CAPITAL (Summary of the Activity in the Share Options) (Details) - Option [Member] - Employees and Members of Board of Directors [Member] - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Number of options
Outstanding at the beginning of the period	339,029
Exercised	(3,645)
Outstanding at the end of the period	335,384	339,029
Weighted average exercise price
Outstanding at the beginning of the period	$ 50.64
Exercised	20.46
Outstanding at the end of the period	$ 50.97	$ 50.64
Weighted Average Remaining Contractual Term In Years
Outstanding	4 years 7 months 17 days	4 years 10 months 9 days
Aggregate Intrinsic Value
Outstanding	$ 84,989	$ 79,414
Exercised	$ 1,073
Vested and expected to vest at the end of the period
Number of options	334,950
Weighted average exercise price	$ 50.8
Weighted average remaining contractual term in years	4 years 7 months 13 days
Aggregate intrinsic Value	$ 84,937
Exercisable at the end of the period
Number of options	311,240
Weighted average exercise price	$ 40.47
Weighted average remaining contractual term in years	4 years 5 months 4 days
Aggregate intrinsic Value	$ 82,079

XML

STOCK CAPITAL (Schedule of RSUs and PSUs Activity) (Details)	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested at beginning of period | shares	1,488,515
Granted | shares	103,081
Vested | shares	(197,866)
Forfeited | shares	(31,296)
Unvested at end of period | shares	1,362,434
Weighted average grant date fair value, beginning of period | $ / shares	$ 232.05
Weighted average grant date fair value, granted | $ / shares	296.64
Weighted average grant date fair value, vested | $ / shares	164.31
Weighted average grant date fair value, forfeited | $ / shares	254.24
Weighted average grant date fair value, end of period | $ / shares	$ 246.27
Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested at beginning of period | shares	149,232
Granted | shares	31,911
Vested | shares	(8,249)
Unvested at end of period | shares	172,894
Weighted average grant date fair value, beginning of period | $ / shares	$ 295.88
Weighted average grant date fair value, granted | $ / shares	314.22
Weighted average grant date fair value, vested | $ / shares	270.93
Weighted average grant date fair value, end of period | $ / shares	$ 300.45

XML

STOCK CAPITAL (Schedule of Stock-based Compensation Expense for Employees and Nonemployee) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	$ 39,235	$ 34,107
Cost of revenues [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	5,927	5,062
Research and development [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	17,209	14,985
Sales and marketing [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	8,079	6,701
General and administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	$ 8,020	$ 7,359

XML

COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details) - 3 months ended Mar. 31, 2023 $ in Thousands, € in Millions	EUR (€)	USD ($)
Non-cancelable purchase obligations		$ 1,617,376
Provision for loss		8,052
Contractual obligations for capital expenditures		121,347
Patents [Member]
Value in dispute	€ 5.5	5,983
Office Rent Lease Agreements [Member]
Guarantees amount		5,876
Projects With Customers [Member]
Guarantees amount		$ 1,899

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Changes in AOCI) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Beginning balance	$ (73,109)
Net current period other comprehensive income (loss)	(4,095)	$ (18,748)
Ending balance	(77,204)	(46,067)
Unrealized gains (losses) on available-for-sale marketable securities [Member]
Beginning balance	(25,449)	(4,709)
Revaluation	7,570	(12,721)
Tax on revaluation	(1,471)	2,471
Other comprehensive income (loss) before reclassifications	6,099	(10,250)
Reclassification	107	844
Tax on reclassification	(29)	(100)
Losses reclassified from accumulated other comprehensive income	78	744
Net current period other comprehensive income (loss)	6,177	(9,506)
Ending balance	(19,272)	(14,215)
Unrealized gains (losses) on cash flow hedges [Member]
Beginning balance	(1,761)	874
Revaluation	(2,196)	(1,337)
Tax on revaluation	139	159
Other comprehensive income (loss) before reclassifications	(2,057)	(1,178)
Reclassification	1,840	565
Tax on reclassification	(114)	(67)
Losses reclassified from accumulated other comprehensive income	1,726	498
Net current period other comprehensive income (loss)	(331)	(680)
Ending balance	(2,092)	194
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment in nature [Member]
Beginning balance	(37,960)	(17,420)
Revaluation	(10,800)	(6,983)
Ending balance	(48,760)	(24,403)
Unrealized gains (losses) on foreign currency translation [Member]
Beginning balance	(7,939)	(6,064)
Revaluation	(859)	(1,579)
Ending balance	$ (7,080)	$ (7,643)

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Reclassifications of Other Comprehensive Income Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Cost of revenues	$ 643,763	$ 476,122
Research and development	79,873	66,349
Sales and marketing	40,966	35,316
General and administrative	36,567	26,429
Total, before income taxes	155,972	128,094
Income taxes	29,325	12,292
Total, net of income taxes	138,378	33,123
Available-for-sale marketable securities [Member] | Amount Reclassified from Accumulated Other Comprehensive Income (Loss) [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Financial income (expense), net	(107)	(844)
Income taxes	29	100
Total, net of income taxes	(78)	(744)
Cash flow hedges [Member] | Amount Reclassified from Accumulated Other Comprehensive Income (Loss) [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Cost of revenues	(212)	(67)
Research and development	(1,129)	(338)
Sales and marketing	(225)	(71)
General and administrative	(274)	(89)
Total, before income taxes	(1,840)	(565)
Income taxes	114	67
Total, net of income taxes	(1,726)	(498)
Total reclassifications for the period	$ (1,804)	$ (1,242)

XML

OTHER OPERATING INCOME (Narrative) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Other Income and Expenses [Abstract]
Sale of property, plant and equipment	$ 1,434

XML

INCOME TAXES (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Income Taxes Schedule Of Taxes On Income Details
Effective tax rate	17.50%	27.10%
Unrecognized tax benefits	$ 2,883		$ 2,756

XML

EARNINGS PER SHARE (Schedule of Computation of Basic and Diluted Net Earnings (Loss) Per Share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Numerator:
Net income	$ 138,378	$ 33,123
Denominator:
Shares used in computing net earnings per share of common stock, basic	56,215,490	53,134,937
Numerator:
Net income attributable to common stock, basic	$ 138,378	$ 33,123
Notes due 2025	552	553
Net income attributable to common stock, diluted	$ 138,930	$ 33,676
Denominator:
Shares used in computing net earnings per share of common stock, basic	56,215,490	53,134,937
Notes due 2025	2,276,818	2,276,818
Effect of stock-based awards	701,523	903,438
Shares used in computing net earnings per share of common stock, diluted	59,193,831	56,315,193
Earnings per share:
Basic	$ 2.46	$ 0.62
Diluted	$ 2.35	$ 0.6
Shares excluded from the calculation of diluted net EPS due to their anti-dilutive effect	192,339	223,776

XML

SEGMENT INFORMATION (Schedule of reportable segments and operating income) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Revenues	$ 943,889	$ 655,080
Cost of revenues	643,763	476,122
Gross profit (loss)	300,126	178,958
Research and development	79,873	66,349
Sales and marketing	40,966	35,316
General and administrative	36,567	26,429
Solar segment profit	206,689	98,712
All other segment loss	(22,886)	(11,522)
Segments operating profit	183,803	87,190
Amounts not allocated to segments:
Stock based compensation expenses	(39,235)	(34,107)
Other unallocated expenses	(414)	(2,219)
Consolidated operating income	144,154	50,864
Solar [Member]
Segment Reporting Information [Line Items]
Revenues	908,505	607,997
Cost of revenues	590,105	424,500
Gross profit (loss)	318,400	183,497
Research and development	55,823	43,131
Sales and marketing	31,145	25,805
General and administrative	24,743	15,849
Segments profit (loss)	206,689	98,712
All Other [Member]
Segment Reporting Information [Line Items]
Revenues	35,197	46,948
Cost of revenues	46,216	44,341
Gross profit (loss)	(11,019)	2,607
Research and development	6,528	7,930
Sales and marketing	1,561	2,574
General and administrative	3,778	3,625
Segments profit (loss)	$ (22,886)	$ (11,522)

XML

SEGMENT INFORMATION (Schedule of reportable segments reconciliation) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Revenues	$ 943,889	$ 655,080
Solar revenues [Member]
Segment Reporting Information [Line Items]
Revenues	908,505	607,997
All other revenues [Member]
Segment Reporting Information [Line Items]
Revenues	35,197	46,948
Revenues from finance component [Member]
Segment Reporting Information [Line Items]
Revenues	$ 187	$ 135

XML

SUBSEQUENT EVENTS (Narrative) (Details) $ in Millions	Apr. 06, 2023 USD ($)
Subsequent Event [Member] | Hark Systems Ltd. ("Hark") [Member]
Subsequent Event [Line Items]
Amount of business acquisition	$ 16.7